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ABSTRACT 
The mortality of peritoneal dialysis (PD) patients is 10 to 20 times higher than that of the age-matched 
general population. Cardiovascular disease (CVD) is the major cause of mortality and morbidity in PD 
patients. Volume overload and artery stiffness are important contributing factors of cardiovascular 
disease. In PD patients, high peritoneal transport status is a major cause of chronic volume overload. 
Since peritoneal vasculature is the principal determinant of peritoneal transport characteristics, these 
three entities (vascular dysfunction, peritoneal transport status, and chronic volume overload) are 
closely linked. 
The assessment of peritoneal transport status is largely standardized. As to vascular dysfiinction, 
arterial pulse wave velocity (PWV) has been successfully used as a non-invasive measurement of 
arterial stiffness. The optimal assessment of volume status in PD patients, however, remains 
controversial. Recently, measurement of vascular pedicle width (VPW) and cardiothoracic ratio (CTR) 
in chest radiograph (CXR) was found to be reliable non-invasive surrogate markers of intravascular 
volume status in critically ill patients. However, they have not been validated in PD patients. 
In this series of work, we aimed (i) to study the relationship between radiographic measurements 
(VPW and CTR) and the clinical outcome of PD patients; and (ii) to study the internal relationship 
between intravascular volume status, arterial pulse wave velocity and peritoneal transport 
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characteristics in PD patients, and to explore whether these parameters are prognostic indictors. 
In the first part, we measured VPW and CTR in 286 unselected prevalent PD patients. VPW was 
further adjusted for the thoracic diameter (VPWR). We found that VPW correlated with age, body 
weight, body height, and Charlson index score, while both CTR and VPWR correlated with the 
duration of hospitalization. However, none of the radiological measurements had independent effect 
on one-year actuarial or technique survival. However, multivariate regression analysis showed that 
VPWR, together with serum albumin and overall score of subjective global assessment (SGA), was an 
independent predictor of hospitalization in one-year. 
In the second part，we enrolled 212 unselected chronic PD patients who were treated for at least 12 
months. Longitudinal changes in VPW (AVPW) and CTR (ACTR) in 12 months prior to enrollment 
were computed. We found that ACTR negatively correlated with hemoglobin, Kt/V and GFR. By 
multivariate Cox regression analysis, ACTR (but not absolute CTR or VPW), mean blood pressure and 
residual GFR, were independent predictors of hospitalization-free survival. 
In the third part, we studied 107 unselected PD patients. VPW and CTR were measured. PWV was 
determined at carotid-femoral (C-F) and carotid-radio (C-R) sites. Peritoneal equilibration test was 
performed and peritoneal trasnport was quantified by the dialysate-to-plasma creatine (D/P) ratio of 
creatinine at 4-hour. Patients were followed for up to one year. In this study, we found no relationship 
7 
between radiological parameters of fluid overload, peritoneal transport characteristics, and arterial 
pulse wave velocity. With multivariate regression analysis, both C-F PWV and dialysate-to-plasma 
ratio of creatinine (a measurement of peritoneal transport rate), but not VPW or CTR, were 
independent predictors of the number of hospitalization for CVD. 
Taken together, this series of work confirms the prognostic value of peritoneal transport and arterial 
pulse wave velocity in PD patients, while radiological markers of intravascular volume status have no 
independent effect after controlling for the former parameters. Our findings suggest that vascular 
dysfunction and peritoneal transport status influence the outcome of PD patients via different 
mechanisms, and chronic fluid overload may not be the major explanation for the excess morbidity 





















在第二部分，我們收集了 212名腹膜透析患者並隨訪一年。我們計算了 VPW和CTR在一年 
內的縱向變化（AVPW和ACTR)�我們發現，ACTR與血紅蛋白，Kt/v和GRF成負相關。多 
重線性回歸表明，A CTR (並非CTR和VPW )，平均動脈壓和GFR是住院率的獨立風險因數。 
在第三部分，我們硏究了 107個腹膜透析患者並測量了 VPW和CTR�PWV通過頸動脈到股動 
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CHAPTER 1 - BACKGROUND REVIEW AND HYPOTHESIS 
LI Overview of Peritoneal dialysis 
End-stage renal disease (ESRD) is one of the most debilitating chronic medical illnesses of mankind. 
Although kidney transplantation, either living-related or cadaveric, is the ideal renal replacement 
therapy (RRT) for ESRD patients [1], the availability of suitable kidney donor is limited [2,3]. Most of 
the patients that suffer ESRD never receive a kidney allograft. In these patients, long-term dialysis is 
the necessary life-sustaining therapy [4]. 
There are two types of long-term dialysis: chronic hemodialysis and chronic peritoneal dialysis [5]. 
Hemodialysis requires a vascular access, an extra-corporeal circuit and an artificial kidney (i.e. the 
hemodialyzer). Uremic toxins and excess body fluid are removed by diffusion and ultrafiltration, 
respectively [5,6]. On the other hand, peritoneal dialysis makes use of the peritoneum, the epithelial 
lining of the abdominal cavity, as the dialysis membrane for the removal of metabolic wastes from the 
circulation [5,7]. In fact, peritoneal dialysis (PD) has been used for over 30 years as RRT [8,9，10]. As 
compared to haemodialysis, PD is a simple, economical and effective alternative [8,10,11]. To date, 
there are over 130,000 patients on PD worldwide, representing approximately 15% of the total world 
dialysis population [9]. 
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How does peritoneal dialysis replace normal renal function? In short, peritoneal membrane is a 
semi-permeable lining [12]. With the instillation of an appropriate peritoneal dialysis solution, uremic 
toxin and excess body fluid are removed from the circulation by diffusion and osmosis, respectively 
[7,12]. Chronic peritoneal dialysis requires the following facilities [7,13]: (1) a permanent dialysis 
access to the peritoneal cavity; (2) a supply of appropriate peritoneal dialysis solution; and (3) a 
connection system to link up the dialysis access with the dialysis solution. 
It is now generally accepted that PD is equivalent to haemodialysis (HD) in terms of clinical outcome 
[9]. Mortality is the same for HD and PD when comparing identical types of patients, at least for the 
first 3 to 4 year of RRT [9]. One of the largest studies [14] that examined 11 970 ESRD patients who 
were started treatment between 1990 and 1994 and were monitored for a maximum of 5 years showed 
that PD patients had marginally better survival than HD patients, although the increased mortality in 
HD was largely confined to the first 2 years of follow-up, and the advantage of PD was lower in 
diabetic patients and patients aged over 65 years [14]. The result indicates that PD has advantage over 
HD in the early years of dialysis, probably because as the initial modality, PD could have better 
preservation of residual residual renal function (RRF), less hemodynamic disturbance, less anaemia, 
lower risk of hepatitis C infection, all contributing to an excellent patient survival [9，15]. Several 
studies even suggest [16] an equal or superior quality of life in PD than HD patients, probably because 
the former provides greater autonomy and free time for education and work. 
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However, PD has its own limitation. Survival advantage for PD is often lost after initial period and 
very few patients remained on PD beyond 8 years [14, 16]. The major reasons of failure of PD as a 
therapy are: continual loss of protein through the dialysate, peritonitis, ultrafiltration failure, and 
inadequate solute clearance when patients become anuric [9,15]. Theoretically, PD patients usually 
need 1.0 to 1.2 g/kg/day dietary protein intake, which is substantially higher than that in HD patients 
(1 g/kg/day). Many patients could not have sufficient dietary protein intake and result in negative body 
nitrogen balance. The situation would be even worse when there is recurrent peritonitis, which 
accelerates the loss of protein through the peritoneum [15]. Peritonitis remains a major cause of patient 
morbidity and the most common reason for transfer to HD [9]. With prolonged PD (with or without 
recurrent peritonitis), loss of ultrafiltration capacity is another common problem, which is often with 
the result of alternation in peritoneal membrane structure and function [9,15]. 
PD undergoes two main era of development since its introduction. During the first two decades, 
technology advances emphasized on catheter design and peritonitis prevention. For example, the 
introduction of "Y-set" catheter connection and the "flush-before-fiH" concept drastically reduce the 
incidence of PD peritonitis [8’ 10]. Since mid-1990s, effort was shifted to the improvement of 
biocompatibility of the dialysis solution in order to preserve peritoneal function [8,10], as well as 
development of stategies to reduce the risk of cardiovascular disease, which has now become the 
major cause of morbidity and mortality in PD patients. 
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1.2 Peritoneal dialysis in Hong Kong 
In Hong Kong, over 90% of the medical care service is provided by the public sector [17]. Being a less 
expensive treatment modality than hemodialysis, PD has become the first line renal replacement 
therapy in Hong Kong since 1994. Since that time, all new ESRD patients who are under the care of 
public hospitals, which take care of over 95% of the Hong Kong population, are treated with 
continuous ambulatory peritoneal dialysis (CAPD) unless there are medical contra-indications (for 
example, previous laparotomy) [13]. The development of this "PD-first policy" has made great 
contribution to a successful dialysis program in Hong Kong [18]. Currently in Hong Kong, 80% of 
ESRD patients on maintenance dialysis are on PD, with most of them being CAPD [18]. The high 
penetration rate of PD in Hong Kong gives an obvious contrast to western countries, at which only 
15 % ESRD patients received PD (less than 5% in Germany, around 30% in the USA) [19]. In 2007, 
there were 3410 PD patients in Hong Kong. Similar to the western world, 40% of all the new dialysis 
patients in Hong Kong had diabetic nephrology as underlying disease, and 21% had 
glomerulonephritis [10]. 
As the hallmark of success, Chinese PD patients enjoyed excellent survival [10]. In a large cohort 
study [20], the 2- and 5-year patient survival rates were 80% and 60% respectively, which compared 
favorably to the CANUSA, ADEMEX and other Caucasian series. Even for patients above 65 year-old, 
the 2- and 5-year patient survival rates were 89 % and 55 % respectively, and technique survival 84 % 
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and 46% repectively [21]. The reason for the excellent survival of Chinese PD patients is incompletely 
understood. Observation studies showed that 76% of white PD patients died of cardiovascular disease 
(CVD), while it was only 53% in Chinese PD patients [10]. Such a difference may be contributed by 
the differences in genetics, dietary habits, life style, culture practices, body size, dialysis prescription, 
prevalence of comorbid condition, and peritoneal transport characteristics [10, 20]. Besides an 
excellent survival, PD patients in Hong Kong also enjoy a good quality of life [10]. For example, 
nearly 90% of the PD patients in Hong Kong are able to do normal daily activity without special care, 
and 70% are able to join social function with little restriction [143]. The peritonitis rate in Hong Kong 
is also low as compared to European centers [19]. For example, previous reports stated that the 
peritonitis rate is one episode every 36 to 45 patient-months in Hong Kong and every 30 
patient-months in European countries [10, 19]. 
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1.3 Cardiovasular Disease in PD patients 
With the advances in connectology and other technical aspects of PD, cardiovascular disease (CVD) 
has replaced peritonitis and become the major cause of mortality and mobidity in PD patients. 
Cardiovascular mortality in PD patients is 10 to 30 folds higher than that in the general population 
[24-29]. About half of the deaths in dialysis patients (irrespective to the mode of dialysis) are due to 
cardiovascular disease, and one-third of all hospitalization in dialysis patients is the result of 
cardiovascular disease [30]. CVD is so common in dialysis patients that the estimated 5-year survival 
of a newly dialyzed patient over 64 year-old is worse than a man with colon or prostate cancer, or a 
woman with breast cancer [30]. 
In fact, patients with chronic kidney disease (CKD) are at high risk of developing CVD long before 
they are dialysis-dependent [22,23]. Patients with CKD, either before or after dialysis, should be 
considered as having an exceptionally high risk of cardiovascular disease [28]. Notably, more CKD 
patients die of cardiovascular disease than of kidney failure per se [28]. A mild degree of renal 
impairment, with the glomerular filtration rate of below 60 ml/min, is sufficient to confer an excess 
risk of cardiovascular disease, and many of these patients succumb to heart disease before progressing 
to dialysis-dependent renal failure [26]. The risk factors of CVD in CKD patients can be summarized 
into traditional risk and uremia-related risk factors (Table 1-1). 
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Table 1-1 Risk factors for CVD in PD patients 
Traditional risk factors Uremia-related risk factors 
Old age Anemia 
Sex (male gender) Fluid overload 
Race Increased oxidant stress 
Arterial hypertension Inadequate dialysis 
Hyperlipidaemia High calcium/phosphorus product 
Diabetes Micro-inflammatory state 
Smoking Left ventricular hypertrophy 





Many well known traditional CVD risk factors are highly prevalent in CKD patients, such as old age, 
arterial hypertension, hyperlipidaemia, and diabetes. In addition, there are uremia-specific risk factors, 
which include anemia, fluid overload, increased oxidant stress, inadequate dialysis, high calcium / 
phosphorus product, and so forth [29-32]. In addition, the presence of proinflammatory cytokines in 
the circulation, persistent intravascular hypervolaemia and arterial hypertension secondary to the 
decline of residual renal function may also contribute to the increase in risk of CVD, while 
hyperphosphataemia, secondary hyperparathyroidism and high calcium / phosphate product may play 
a role in the progression of arterial and valvular calcifications in dialysis patients [29]. It should be 
noted that CKD patients have a lower prevalence of some traditional CVD risk factors (such as obese 
and hypercholesterolemia) than the general population [26]. However, the coexistance of diabetes, 
hypertension, left ventricular hypertrophy (LVH), low HDL high oxidant stress, and elevated 
circulating level of inflammatory cytokines in CKD patients have an overwhelming effect and lead to 
the high prevalence of CVD in this group of patients [26]. 
The most common forms of CVD are coronary artery disease, congestive heart failure, and sudden 
cardiac death [31]. Arterial calcification and LVH are also commonly observed and may predict 
cardiovascular mortality in dialysis patients [25,26]. In dialysis patients, cardiovascular mortality has 
been estimated to be approximately 9% per year, while the prevalence of coronary artery disease and 
LVH are 40% and 75% respectively [28]. 
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1.3.1 Arterial disease 
Arteries are a unique system that contain blood output from heart and provide continuous flow to 
tissues [33]. However, arterial dysfunction is common in ESRD patients as a result of extensive 
intimal and medial calcification [25]. Two related but distinct processes should be considered: intimal 
calcification is a feature of atherosclerosis, with characteristic accumulation of cholesterol cyrstals, 
inflammation, infiltration of myofibroblast, and development of focal plaques [34]; medial 
calcification is, on the other hand, associated with arterial sclerosis and manifests as stiffness of the 
arterial wall [34]. Although atherosclerosis or intimal thickening is common in CKD patients, arterial 
medial calcification is the characteristic feature because they are much less common in non-renal 
failure subjects. It was estimated that dialysis patients have 2 to 5 times risk of suffering arterial 
calcification as compared to age-matched general population [25]. 
There are important differences in the anatomical distribution between atherosclerosis and 
arteriosclerosis: the former presents as arterial plaques that are focal, intermittent in distribution, 
occlusive in nature, and with a predilection for arterial bifurcation site, while the latter is a more 
generalized process that would lead to vascular remodelling, resulting in thickened, dilated, and 
noncompliant arteries with significant haemodynamic consequences [24]. The clinical relevance of 
intimal calcification and atherosclerosis has been well recognized. Arterial medial calcification, 
however, develops rapidly in CKD patients and probably have substantial contribution to the high 
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incidence of cardiac and vascular complications in this group of patients [35]. Increase in arterial 
stiffness leads to CVD by increasing myocardial oxygen demand, subendocardial ischemia and 
vascular afterload, resulting in the development of LVH [36]. Specifically, arteriosclerosis leads to 
diminished arterial distensibility, enhanced arterial wave reflections, increased pulsatile work of the 
heart, as well as decreased subendocardial coronary perfusion [24]. The term "arterial disease", 
therefore, does not only refer to the presence of atherosclerosis as a cause of cardiovascular disease, 
but also to alterations of the vascular system secondary to arteriosclerosis [24,25]. 
One particular form of arterial disease is common in CKD patients and worth special mentioning: 
coronary artery calcification [36,37]. The high prevalence of coronary artery calcification in CKD 
patient is partly due to the high prevalence of CVD risk factors in this group of patients, and partly due 
to unique changes in CKD with the formation of calcification plaques [37]. Approximately 70% 
ESRD patients have significant coronary artery calcification, suggesting the presence of substantial 
coronary atherosclerosis. [36,37]. One recent study [36] examined the difference in coronary 
atherosclerotic lesions between ESRD and age and gender-matched controls, and showed that the 
plaque was more calcified in the ESRD population than controls. In this study, there was no difference 
in the intimal thickness between two groups, but arterial medial thickness was significantly greater in 
the ESRD patients. The results supported the notion that medial calcification is the characteristic 
lesion of CKD, although atherosclerosis and intimal thickening are also common. 
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1.3.2 Left ventricular hypertrophy 
In addition to arterial diseases, left ventricular hypertrophy (LVH) is another common cardiovascular 
abnormality found in dialysis patients [25]. LVH includes concentric and eccentric forms (Figure 1-1). 
The former is the result of pressure overload, which is caused by hypertension and arteriosclerosis, 
and manifests as increase in myocyte thickness but little change in left ventricular volume; the latter is 
caused by volume overload and manifests as myocardial wall thickening together with increase in left 
ventricular volume [25,26]. 
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Figure 1-1. Left ventricular geometry and the two forms of ventricular hypertrophy. 
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In addition to pressure and fluid overload, several other factors contribute to the development of LVH， 
including coronary artery disease, hyperparathyroidism, anemia and malnutrition [26]. Severe uremia 
per se may also cause myocyte death, reduction in capillary density, and increase in myocardial 
fibrosis [25]. In a previous study, low glomerular filtration rate (GFR), high systolic blood pressure, 
and low hemoglobin level are independent risk factors of LVH [25]. The prevalence of LVH correlates 
with the degree of renal impairment [25], and varies according to GFR: 27% in patients with GFR > 
50 ml/min, 31% with GFR 25 to 49 ml/min, and 45% with GFR < 25 ml/min [25]. 
The major physiological consequence of LVH is diastolic dysfunction, which would result in increase 
in left ventricular end diastolic pressure, eventually leading to reduced cardiac output and pulmonary 
congestion [26, 38]. Clinically, patients have a low threshold of developing pulmonary edema [26，30]. 
Dialysis patients may experience unstable homodynamic status during ultrafiltration, leading to a 
sharp fall in blood pressure during dialysis [26]. 
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1.4 Malnutrition in PD patients 
In PD patients, another problem that often develops at the same time with cardiovascular disease is 
malnutrition. Malnutrition is common in dialysis patients [39,40]. It is widely accepted that 
malnutrition is a predictor of morbidity and mortality in dialysis patients [40,41]. CANUSA study 
showed decreased in serum albumin concentration was related with increased in technique failure and 
hospitalization [40]. 
There are two types of malnutrition could be discerned in chronic renal failure patients [39,42]: Type-I 
malnutrition is associated with uraemia syndrome, co-morbidity is uncommon and levels of 
pro-inflammatory cytokines are usually not elevated. The main character of this type is low serum 
albumin as a result of low protein intake and the condition could be reversed by adequate dialysis and 
nutrition support. Type-II malnutrition, on the other hand, is often accompanied by co-morbidity and 
systemic inflammation. This "cytokine-driven" type of malnutrition is characterized by low serum 
albumin, increased protein catabolism, elevated resting energy expenditure and increased oxidative 
stress, and the condition is typically resistant to adequate dialysis and nutrition support. The two types 
of malnutrition, however, often overlapped in most PD patients. 
A variety of factors may contribute to malnutrition [39,40,43]. Firstly, the most important factor is 
probably inadequate nutrient intake, which could be due to inadequate dialysis, dietary restrictions, old 
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age, psychological and socioeconomic factors (such as poverty, depression) and suppressed appetite 
(for example, because of increase in intra-peritoneal pressure, absorption of glucose from dialysate 
and various medications). Secondly, the loss of proteins and amino acids from peritoneum may 
contribute to malnutrition. Dialysis patients typically lose 6 to 9 g/day protein daily, and the figure 
may be much higher when there is peritonitis. Finally, increased catabolism due to co-existing 
systemic diseases, infections, chronic inflammation, underdialysis and metabolic acidosis may all 
contribute to malnutrition. 
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1.5 Fluid overload in PD patients: a cause and a result of CVD 
1.5.1 Overview 
One cardinal feature of PD patients that may cause or be the result of CVD is chronic fluid overload. 
The body water is divided into the intracellular fluid (ICF) (40% of body weight) and the extracellular 
fluid (ECF) (20% of body weight). The two compartments are separated by the cell membrane, in 
which the sodium-potassium pump maintains the sodium concentration at less than 8 mniol/1 in the 
ICF and around 140 nimol/1 in the ECF [44]. Volume overload or overhydration often refers to an 
expansion of the volume of body fluid or simply its extracellular component, with or without 
generalized or localized edema [44]. The causes of volume overload include decrease in salt and water 
excretion or increase in retention of salt and water, and loss of plasma oncotic pressure [44,45]. 
Fluid status and volume homeostasis are extremely important in patients with CKD, and fluid overload 
is very common in PD patients [46,47]. Many studies indicated that preservation of volume control is 
the key component of an "adequate" peritoneal dialysis. Volume overload is one of the most important 
manifestations of CVD, and a major cause of PD mortality [48-51]. A previous study [48] showed that 
an extra 250-ml volume removal would reduce the risk of death by 36%. Another study [46] showed 
that patients who survived on PD had significant lower extracellular water (ECW) than those who died, 
and ECW was a significant independent predictor of PD mortality after adjusting for age, race, 
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diabetes, human immunodeficiency virus (HIV) status, and duration of dialysis. Another study showed 
that inadequate fluid and sodium removal is a predictor of increased hospitalization rate and mortality 
in PD patients [50]. 
1.5.2 Fluid overload and residual renal function 
Dialysis patients with substantial residual renal function (RRF) have advantages of needing shorter 
dialysis and less dietary and fluid restriction [52]. RRF contributes to salt and fluid removal, and is 
largely responsible for the removal of middle and large size molecules. Dialysis patients with 
substantial RRF is associated with a better control of phosphate and potassium, less anemia, and lower 
dosage of erythropoietin, better nutritional status and quality-of-life, better metabolic profiles, and 
better survival [52,53]. RRF is important for both HD and PD patients, and is a major predictor of 
morbidity and mortality in dialysis patients [52,54-46]. The preservation of RRF is associated with 
better patient survival in PD: it was estimated that each 250 ml urine output was associated with a 36% 
reduction in overall mortality [57]. Loss of residual renal function compromises both fluid removal 
and solute clearance, leading to worsening of uremic symptom and increased mortality [56]. 
Nearly all dialysis patients have progressive loss of renal function. The gradual decrease in urine 
output causes fluid overload and worsening of hypertension [54]. It is important to realize that 
hyervolemia secondary to the loss of residual renal function may be one of the important contributing 
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factors for the adverse cardiovascular outcomes [57]. A greater extracellular fluid volume was 
observed in PD patients with residual glomerular filtration rate (GFR) below 2 ml/min as comapred to 
those with residual GFR above 2 ml/min [57]. More importantly, the control in fluid status often 
becomes difficult after the loss of RRF, which usually occurs two years after the initiation of dialysis 
[50]. 
It is well recognized that the loss of RRF is more rapid in HD than CAPD. It is usually believed that 
on the stable hemodynamic status of CAPD helps to preserve RRF. Furthermore, recurrent volume 
overload in itself might lead to a faster decline of residual renal function [58], resulting in a vicious 
circle. 
1.5.3 Fluid overload and hypertension 
Hypertension is present in 80% to 90% of ESRD patients [59,60]. Hypertension is an independent 
predictor of mortality in PD patients and an important risk factor for CVD in CKD patients [36，50, 61， 
62]. High blood pressure (BP) may develop early in the course of CKD, and there is strong 
relationship between systolic BP (SBP) and diastolic BP (DBP) and the rate of progression to ESRD, 
regardless of other known risk factors [63]. 
Fluid and sodium excess is the cardinal cause of hypertension in CKD patients. In the classical Guyton 
model [64], hypertension results from the so-called pressure-diuresis mechanism: the kidney is 
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considered to be a filter and, each given value of sodium intake is equal to urinary sodium output in 
steady-state conditions, and a given steady state mean blood pressure is achieved. As hypertension 
develops, the renal filter is altered and a higher mean blood pressure is required to maintain sodium 
balance. So there is a shift of the pressure-diuresis curve toward higher blood pressure values. In 
essence, kidney is responsible for the removal of sodium and water; loss of renal function inevitably 
causes clinical or subclinical volume expansion, which is now considered as the most important factor 
in the development and maintenance of hypertension in renal failure [60,65]. A previous study [38] 
also showed that hypertension is related with renal sodium excretion, and sodium intake affects total 
body water and extracellular volume (ECV). Increased sodium intake increases ECV overload through 
thirst and water ingestion [38]. On the other hand, diseased kidney may secrete a number of vasoactive 
substances (for example, renin and angiotensin II)，which may trigger hypertension. It is important to 
recognize that the presence of hypertension further accelerates the progression of renal disease by 
direct glomerular injury and worsening of proteinuria (which in turn promote further glomerular and 
tubulointerstitial injury) [63]. Interestingly, PD is often effective in reducing blood pressure during the 
first 2 to 3 years of dialysis, but with the decline of RRF or peritoneal ultrafiltration failure, control of 
hypertension often becomes difficult [66,67]. 
From the above discussion, it becomes obvious that blood pressure is often a surrogate indictor of 
ECV [32]. Normal BP in a dialysis patient often indicates the absence of extra ECV and the 
achievement of the "dry weight" [32]. However, BP control is poor in the majority of dialysis patients 
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because it is difficult both to determine and to achieve the dry weight [32]. Several studies [68-71] 
have shown that BP target could be achieved by strict control of the volume status. In one study [50], 
sodium removal and fluid removal negatively correlated with SBP and DBP. Many authorities [50,72] 
now suggest rigorous control of BP and normalization of extracelluar volume as one of the major parts 
of adequacy in PD treatment, and excellent BP control can be achieved by strict volume control, 
without the use of antihypertensive drugs [66]. 
The detrimental effect of chronic hypervolemia is more profound than that on blood pressure 
numerically. The volume overload in PD patients increases tensile stress on the arterial wall, resulting 
in vessle remodeling and hypertrophy of the surrounding media smooth muscle; the hypertrophied 
vessel becomes less compliant, leading to even a higher systolic pressure and a vicious circle [67]. 
However, not all hypertensive CKD patients have volume overload, and there was large overlap in 
fluid status between normal and hypertensive CKD patients [70]. Nomiotensive PD patients may also 
have substantial fluid overload [67]. 
1.5.4 Fluid overload and malnutrition 
It has been suggested that improved fluid status is associated with improvement in nutritional status, 
whereas deterioration in fluid status is associated with the development of malnutrition [73]. In a 
prospective study, Wang et al [74] divided 28 PD patients into two groups: one was given continuous 
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and steadily improved fluid status, while the other had persistent fluid overload. After follow up for 9 
months, the former group showed improvement in the control of fluid status with a significant 
improvement in nutritional status, while nutritional status deteriorated significantly in the latter group. 
The mechanism that fluid overload causes malnutrition is complex. On one hand, chronic 
gastrointestinal edema reduces the appetite and possibly causes a certain degree of malabsorption. 
Other mechanisms may also be in play. For example, in normal subjects, albumin leaks out of the 
circulation into the interstitial space at a rate of 5% per hour and is returned to the circulation via the 
lymphatic system [73]. However, PD patients have abnormal microcirculation environment, albumin 
leak from the intravascular to the interstitial space is substantially increased, causing the fall in serum 
albumin concentration [73]. This process is further accelerated by inflammation, partly contributing to 
the link between malnutrition and fluid overload in PD patients. In one study [75], 43 CAPD patients 
were recruited to monitor nutritional status (SGA and serum albumin as nutritional index), 
inflammation (CRP as index) and volume status (ECW and TCW as index) and found CRP and ECW 
were positively correlated with variable nutritional status and continual malnutrition, which supported 
inflammation and volume overload may be related to malnutrition in CAPD patients 
1.5.5 Assessment of fluid status in PD patient 
Unfortunately, there is no simple and reliable method for the evaluation of volume status in PD patiens 
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[76]. Physical examination for the presence of ankle edema or elevated jugular venous pressure is not 
absolutely reliable and could only detect grossly abnormal body water volume. Traditionally, body 
fluid compartment is mesured by solute or isotope dilution methods. Specifically, total body water 
could be measured by tritium or deuterium dilution study, extracellular fluid could be measured by 
dilution assay of inulin, mannitol, sucrose, thiosulfate, bromide, ^^Cl, or '^^ Na (although most of 
these substances have diffusion into intra-cellular space to a certain extend), and plasma volume could 
be measured by dilution studies that use albumin labelled with T-1824 (a special dye) or ⑶】，o r 
99mTc. It is, however, important to note that there is no reliable method to measure intracellular fluid 
volume directly, and all of the above mentioned methods are cumbersome and hardly ever used in 
routine clinical practice. 
Recently, measurement of vascular pedicle width (VPW) in chest radiograph (CXR) was found to be a 
reliable non-invasive surrogate marker of intravascular volume status in critically ill patients [77-79]. 
VPW is the mediastinal silhouette of the great vessels in the CXR. The objective measurement of the 
VPW obtained from either upright or supine CXRs, which are often already available though not fully 
utilized, can increase the accuracy of the clinical and radiographic assessment of intravascular volume 
status by 15 to 30% [80], and the accuracy may be even higher when VPW is used serially within the 
same patient. Regardless of the presence or absence of pulmonary edema, the best VPW cutoff for 
differentiating a high versus normal to low intravascular volume status is 70 mm using upright films. 
Patients with a VPW of over 70 mm coupled with a cardiothoracic ratio of over 0.55 are more than 
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three times more likely to have a pulmonary artery occlusion pressure of over 18 mmHg than are 
patients without these radiographic findings [77]. 
In non-renal failure patients, changes in intravascular fluid volume can be reflected by VPW [77,80]. 
Temporal fluid balance changes are reflected on commonly utilized portable CXRs, and VPW is the 
most sensitive objective radiographic measures of intravascular volume [78]. Martin et al [78] and 
Milne et al [80] both showed that VPW has a positive correlation with measured total blood volume 
[78,80]. However, the utility of VPW as a surrogate marker of intravascular volume status in PD 
patients has not been studied. 
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1.6 Peritoneal transport as the cause of fluid overload 
1.6.1 Structure of peritoneum 
The development of chronic fluid overload in PD patients is often the result of problems in peritoneal 
transport. The peritoneal membrane consists of a single layer of mesothelial cells and a basement 
membrane overlying a thin interstitial layer of connective tissue with fibroblasts, mast cells, 
macrophages and blood vessels [81-83]. The mesothelial cells play a major role in host defense and 
secretion of lubricant [81]. Substances that are synthesized in mesothelial cells are often considered as 
markers of peritoneal membrane function and their levels can be detected in the effluent dialysate [84]. 
For example, CA125 is commonly used as a marker of mesothelial cell mass. 
Peritoneal membrane is a barrier between blood and peritoneal fluid [85]. Any solute in the blood 
needs to pass three resistances (the capillary, the interstitium and the mesothelium) to reach the 
peritoneal dialysate [85]. The barrier could best be explained by the construct "three pore model": 
ultrapores with a radius of below 0.8nm and is only permeable to water; small pores with a radius of 
4.0 to 6.0 nm are responsible of small solute (which are transported by diffusion, such as urea); and 
large pores with a radius of 20 to 40nm are permeable to macromolecules (which are transported by 
convection, such as protein) [81,85,86]. It is important to realize that, capillary endothelium, rather 
than mesothelial cells, is the major barrier of peritoneal solute transport [84]. 
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1.6.2 Structural alteration of peritoneal membrane in PD 
Commercially available solution for peritoneal dialysis has a high osmolality as a result of high 
glucose concentration. After prolonged exposure to this kind of unphysiological dialysate, peritoneal 
membrane undergoes structural alterations, which can be summarized into four aspects: mesothelia 
cell denudation, fibrosis, angiogenesis and vasculopathy [25,81,83]. Structural alterations are 
considered to be the major contributor of ultrafiltration failure [25]. 
Epithelial-to-mesenchymal transition (EMT) is a key phenomenon in peritoneal fibrosis and 
angiogenesis [25,31,81,83,87]. EMT is generally believed to be initiated by TGF-B, which plays an 
important role in triggering and perpetuating wound healing [25,31,81,83]. EMT involves three steps: 
first, the dissociation of intercellular junction, causing down-regulation of adhesion molecules such as 
occludin; second, polarity transition, in which the front-back polarity replaces apical-baselateral 
polarity; and third, loss of epithelial phenotype and expression of myofibroblast-like characteristics 
(an intermediate feature between fibroblast and smooth cell) and migration to sub-mesothelial stroma 
[25,83]. The secretion of extracellular matrix and vascular endothelial growth factor by the 
transformed mesothelial cells may participate on later development of fibrosis and high peritoneal 
permeability [87]. EMT is a frequent morphological change in the peritoneal membrane, and high 
peritoneal solute transport status is often associated with the presence of mesothelial cell EMT [88]. 
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1.6.3 Ultrafiltration dysfunction 
Ultrafiltration (UF) failure is a common consequence of prolonged PD, with or without the insult of 
repeated peritonitis. It is also a common cause of morbidity and technique failure of PD patients [89]. 
It has been estimated that nearly 50% PD patients have to stop using PD because of ultrafiltration 
failure [90]. Histological studies reveal that modification of peritoneal membrane appears in prolonged 
PD patients with characteristic of increased density of blood vessel and endothelia area, interstitial 
fibrosis and mesothelial alternation [89]. 
The commonly used definition of UF dysfunction is net UF below 400 ml using 4-h peritoneal 
equilibrium test (PET) with 4.25% dextrose solution [48,82,84]. There are two types of UF failure: 
type I UF failure is related with high peritoneal solute transport and rapid dissiptation of osmotic 
gradient of dailysis solution; it is the common type in PD patients; type II UF failure is related with 
low peritoneal solute transport and failure of all solute and solvent to pass through the membrane [45]. 
The reason of UF failure can be summarized into non-membrane-related causes (such as catheter 
malposition) and membrane-related causes [48]. Currently, three main mechanisms are supposed to 
contribute to membrane-related UF dysfunction: 
First, expansion of peritoneal vasculature plays a major role in increased solute transport and 
ultrafiltration failure [25,82]. Several studies have already confirmed the negative relationship 
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between angiogenesis in the peritoneal membrane and the development of UF failure [82]. It is 
because vascular surface area determines the number of small pores across the peritoneal membrane. 
Angiogenesis increases vascular surface area, resulting in the rapid loss of osmotic gradient in the 
dialysate [48,82]. Increased diffusive peritoneal transport rate also results in rapid glucose absorption 
from the dialysate [91]，contributing to obesity, hyperglycemia, hyperinsulinemia, hyperlipidemia, and 
probably insulin resistance and metabolic syndrome in PD patients [91]. 
Second, aquaporin-1 (AQPl), a 28-kD protein abundantly expressed in the endothelial cells lining the 
capillaries and small veins in the peritoneal membrane, is responsible for half of the UF [84,92,93]. 
AQPl corresponses to the "ultrasmall pore" predicted by the three-pore model of peritoneal transport 
[84]. Some studies [48,81,82] have suggested a relationship between aquaporin expression and UF 
dysfunction, with disabled aquaporin decreases fluid removal. 
Third, excessive lymphatic absorption may contribute to UF failure. The cause of increase lymphatic 
reabsorption is not clear. It has been suggested that supine position and large dwell volume may 
increase dialysate absorption [82,92]. Lymphatic absorption varies in different patients and time; the 
usual dialysate absorption rate is 60 to 100 mL per hour, or 250 to 400 mL with a 4-hour dwell [92]. 
However, direct lymphatic absorption is only of minor component of fluid absorption in most PD 
patients [94]. 
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1.6.4 Peritoneal transport and outcome of PD patients 
High peritoneal transport is now considered to be related to the mortality and risk of technique failure 
in PD patients [95]. However, the association is far from conclusive. In one study, Yang et al [96] 
followed 193 PD patients for 5 years and patients were devided into 4 groups according to the baseline 
peritoneal transport status: low (L)，low average (LA), high average (HA), and high (H). At the end of 
1, 3’ and 5 years, patient survival was 91%, 82%, and 67% in LA group; 95%，77%, and 69% in HA 
group; and 96%, 71%, and 71% in H group. Technique survival was 100%，90%, and 77% in LA 
group; 96%, 84%，and 72% in HA group; and 92%, 87%, and 77% in H group. It was concluded that 
high peritoneal permeability did not result in a worse patient survival or a higher risk of technique 
failure. On the contrary, one of the largest studies in Australia or New Zealand [95] enrolled 3702 
individuals who began PD treatment and were followed for 6 years. In this study, it was concluded 
that peritoneal transport rate is a highly significant risk factor for both mortality and death-censored 
technique failure in the incident PD patient populations. 
The reasons for these conflicting observations are uncertain, but may be due to different sample size, 
variable duration of follow-up and other unidentified clinical confounding factors [95]. Recently, 
Chung et al [91] suggested that "fast transporters" could be divided into three different types: Type I 
patients have poor prognosis who are inflamed and have high prevalence of comorbidities and 
mortality; the peritoneum is characterized by vasculopathy and endothelial dysfunction. Type II 
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patients have better prognosis without inflammation and the peritoneum is characterized by increased 
peritoneal surface area. Both types I and II refer to new PD patients. Type III develops after prolonged 
PD, primarily due to structural changes in the peritoneal membrane as a consequence of the 
continuous exposure to bioincompatible PD solutions. The clinical relevance of this classification 
remains to be determined. 
1-6.5 Fluid overload and peritoneal transport 
One major contributor to the chronic fluid overload of PD patients is peritoneal transport status. The 
relationship between peritoneal transport and fluid status has been explored in several studies. For 
example, Wang et al [72] compared the fluid status, peritoneal solute transport, and clinical outcome in 
CAPD patients with high (H), high-average (H-A), low-average (L-A) and low (L) peritoneal transport 
patterns, and showed that high transporters removed less fluid and small solutes, but had a higher 
protein loss and more glucose absorption, all contributing to fluid overload, malnutrition and lipid 
abnormalities, resulting in increased mortality among the high transporters. This study strongly 
supports the notion that high peritoneal transport leads to fluid overload as well as nutritional and 
metabolic alterations. Another study [97] also showed an inverse relationship between peritoneal 
transport characteristics and ultrafiltration volume. It is generally agreed that high transporter leads to 
fluid overload, which is one of the driving forces for ventricular hypertrophy, hypertension, and 
increased cardiovascular risk [98]. 
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It is important to realize that arterial stiffening is associated with endothelial dysfunction and increased 
microvascular permeability, which is the major determinant of peritoneal transport rate [97]. Increased 
endothelial permeability is often the result of accumulation of low-density lipoprotein in the vessel 
wall, which comes together with arterial stiffening [97]. In a study of 76 PD patients, Konings et al [97] 
evaluated arterial stiffness, fluid overload and peritoneal characters in forms of PWV, extracellular 
water over total body water (E/T ratio) and dialysate-to-plasma (D/P) creatinine ratio, and showed a 
positive relationship between PWV, E/T ratio and D/P, while both E/T and D/P were the independent 
predictors of PWV. The result highlights the close relationship between arterial stiffness, peritoneal 
transport, and fluid status of PD patients. The findings are confirmed in another study of 65 PD 
patients by the same group of investigator. 
1.6.6 Peritoneal transport and malnutrition 
In theory, high peritoneal transport results in excessive peritoneal loss of nutrients, which would lead 
to deterioratiion in nutritional status [99]. Increased protein loss into dialysate may contribute to 
hypoalbuminemia, lipid abnormalities, loss of antioxidant capacity, and edema [91]. In addition to 
peritoneal albumin leakage, ultrafiltration dysfunction in high peritoneal transport status may cause 
plasma volume expansion, which may also worsen nutrition status indirectly [99]. 
Several studies [100-102] further suggest a relationship between high peritoneal membrane transport 
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status, malnutrition and chronic inflammation. Sezer et al [99] demonstrated high peritoneal transport 
status and peritoneal albumin leakage were significantly associated with the Malnutrition 
Inflammation Score, which is an indicator of the degree of systemic inflammation as well as 
malnutrition. Margetts et al [102] examined the relationship between serum albumin and peritoneal 
membrane transport status before and after the initiation of PD and showed that an inverse association 
between peritoneal membrane transport and serum albumin is already present before initiation of 
dialysis. 
However, that the association between peritoneal transport and nutritional status of PD patients is not 
universally accepted. One previous study [16] showed that malnutrition was inversely correlated with 
body surface, hemoglobin, and residual renal function, but not with peritoneal transport status. On this 
aspect, it should be noted that serum albumin - which often correlates with peritoneal transport status 
and is often taken as a marker of malnutrition - is not a good nutritional marker but more a marker of 
inflammation or underlying comorbidity [91]. In another study of 235 PD patients, for example, Szeto 
el at [102] showed a weak correlation between 4-hour dialysate-to-plasma ratio of creatinine and 
baseline serum albumin; high transport character was a specific but not a sensitive predictor of poor 
baseline nutritional status. In this study, peritoneal transport status was not associated with 
longitudinal change of nutritional parameters. 
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1.6.7 Assessment of peritoneal transport 
Because of the pivotal importance of determining peritoneal transport status in PD patients, a number 
of tests have been proposed for such a purpose. Amongst them, the Peritoneal Equilibration Test (PET) 
is the most commonly used one. The PET was the first standardized method to quantify individual 
peritoneal membrane characteristics. The results of the PET have been found to be highly reproducible. 
The procedure is summarized in Table 1-2. Based on population studies, patients are categorized as 
low, low-average, high-average or high transporters. However, PET is directed primarily at small 
solute clearance and the conventional PET does not directly address the pathology of UF problem. It 
has been suggested that the procedural steps in the PET may actually overestimate peritoneal 
membrane transport and underestimate the variation in peritoneal transport that may occur under 
actual clinical conditions [104]. Moreover, it is imperative to be aware that the PET alone does not 
give an assessment of dialysis adequacy. 
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TABLE 1-2. Procedure of Peritoneal Equilibration Test (PET)* “ 
1. After an overnight exchange of an 8 tol2 hour dwell, 2 liters of 2.5% glucose 
concentration solution is instilled and allowed to dwell for 4 hours 
2. Several times during the dwell the patient is requested to roll from side to side 
3. Dialysate urea, glucose, sodium and creatinine are measured at 0, 2 and 4 hours 
4. A blood sample is taken after 2 hours 
5. The drain bag is measured to assess both drain and net ultrafiltration volume 
6. Dialysate-to-plasma ratios (D/P) are calculated for creatinine, urea and sodium at 0, 2 and 
4 hours 
7. The ratio of glucose at drain time to the dialysate glucose concentration at time 0 (Dt/DO) 
is measured 
•Adapted from [103]. 
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Since the PET is labor intensive, the fast PET [105] provides a simpler alternative by requiring only 
one dialysate sample. After draining the overnight dwell, the patient starts an exchange at home and 
arrives at the center in time for drainage of this 4-hour dwell. A blood sample is taken at the end of the 
exchange. The analysis of the fast PET is identical to that for the standard PET. However, only two 
reliable measures of peritoneal membrane permeability are determined, D/P creatinine and dialysate 
glucose after 4 hours. If these 2 measures give contradictory results, it may be difficult to accurately 
interpret the test. 
A number of other alternative tests have also been described. These include the short PET [106], the 
Peritoneal function test (PFT) [107,108], the Peritoneal dialysis capacity (PDC) program [109,110], 
the Dialysis adequacy and transport test (DATT) [111,112], the Accelerated peritoneal examination 
(APEX) [113], and the Standard peritoneal permeability analysis (SPA) [114]. None of these tests, 
however, is commonly used in clinical practice. 
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1.7 Closing the circle: Arterial stiffness as a cause of high peritoneal transport? 
1.7.1 Vascular function and anatomy 
As discussed above, vasculature is the major determinant of peritoneal transport resistance because 
arterial stiffening is associated with endothelial dysfunction and increased microvascular permeability, 
which is the major determinant of peritoneal transport. It would therefore be important to understand 
vascular physiology under normal and diseased conditions. The arterial system is composed of a 
branching network of elastic conduits (aorta), muscular conduits (medium size arteries), and high 
resistance vessels (arterioles), all of which severe to deliver blood from heart to peripheral organs as 
well as reduce blood pressure oscillation caused by ventricular ejection [24,115]. Conduit and 
dampening are the two important functions of the arteriral system [35,64]. Conduit function is to carry 
the blood from heart to tissues and organs for their metabolic needs [35,64]. Dampening function is to 
store part of the cardiac output in the arterial system during systole, with the aim to maintain a forward 
blood flow during diastole in order to ensure continuous perfusion of peripheral tissues [47]. All 
arteries consist of three layers: tunica intima, tunica media and adventitia (Fig 1-2) [81,86]; Intima 
encompasses the endothelium and sub-endothelial space; media is composed of smooth muscle cells, 
elastic fibers and collagen fibers; adventitia consists of bundles of loosely arranged collagen and 
elastic fibers as well as lymphatics and nerves [86]. 
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Figure 1-2. The three layers of artery 
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Fig 1-2. All arteries consist of three layers: tunica intima, tunica media and adventitia; Intima 
encompasses the endothelium and sub-endothelial space; media is composed of smooth muscle cells, 
elastic fibers and collagen fibers; adventitia consists of bundles of loosely arranged collagen and 
elastic fibers as well as lymphatics and nerves. 




Atherosclerosis is the most common condition affecting the arterial system. It is a chronic 
inflammatory response in the walls of arteries, largely due to the accumulation of macrophages and 
myofibroblasts, and promoted by lipoprotein deposition. It could be broadly regarded as a change in 
area, diameter, and volume of an artery, which eventually leads to thick and stiff arterial walls, change 
in the mechanical properties, progressive narrowing and occlusion of the artery (Fig 1-3)[115]. 
Arterial narrowing reduces the conduit function and results in organ ischemia, which are mainly 
observed in the brain, the heart, and the kidneys [35,64]. Further, when the arterial wall becomes stiff, 
the dampening function decreases [35]. Atherosclerosis is the most frequent underlying pathology of 
cardiovascular disease in the general population as well as ESRD patients [35]. 
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Figure 1-3. Comparison between normal and narrowing artery 
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A. The normal artery had normal blood flow passing through without plaque. 
B. Narrowing of artery with plaque had abnormal blood flow passing through. Narrowing artery had 
a change in area, diameter, and volume of an artery, which eventually leads to thick and stiff 
arterial walls, change in the mechanical properties, progressive narrowing and occlusion of the 
artery. 
(free educational material from School of Anatomy and Human Biology - The University of Western 
Australia) www.lab.anhb.uwa.edu.aii/mbl40/CorePages/VasciilarA^asculai'.htm 
1.7.3 Atherosclerosis and Endothelial Dysfunction 
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The endothelium maintains normal vascular tone, with no or little expression of proinflammatory 
factors under normal homeostatic conditions [116]. Endothelium, acting as the messenger between the 
blood stream and vessel wall, is an important regulator of the vascular smooth muscle tone [81,86]. 
Endothelial cell has secretory function: it releases vasoconstrictive (such as endothelin) as well as 
vasodilating factors (such as nitric oxide) [86，115]. Endothelial cells normally maintain a balance 
between vasoconstrictive and vasodilating factors and take part in the auto-regulation of blood flow to 
individual organ system [86]. The balance, however, could be disturbed by a number of factors, such 
as metabolic (hypercholesterolemia, diabetes, smoking), physical (hypertension) and degenerative 
(age) ones. Typically, impaired endothelial function is characterized by reduction of vasodilating 
factors and an increase in endothelium-derived vasocontracting factors [86，116]. Furthermore, the 
functional disturbance of endothelium would progress to structural abnormality of the vessel wall if 
the inciting insult persists [81,83,86]. 
Oxidative stress and inflammation have now been recognized as important factors contributing to the 
development of endothelial dysfunction and possibly atherosclerosis [117]. Vascular endothelium is 
the major target of oxidative stress, which increases vascular endothelial permeability and promotes 
leukocyte adhesion, resulting in alterations in endothelial signal transduction and redox-regulated 
transcription factors [116]. Impaired endothelial function could further leads to lipid accumulation, 
smooth muscle proliferation, and vasospastic response in both medium and small sized arteries, all 
being initiating mechanisms that lead to atherosclerosis. In renal failure patients, atherosclerosis 
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contributes to the progression of renal disease and in turn may exacerbate endothelial dysfunction (for 
example, via accumulation of uremic toxin), resulting in a vicious cycle [24,62，116’ 117]. 
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1.7.4 Atherosclerosis and Extracellular Matrix 
Although endothelium plays the major regulatory role, extracellular matrix is the major building block 
of the arterial system. Collagen and elastin are important components of the tunica media of artery, 
and maintain the structural integrity and elasticity, respectively, of the artery [8，118]. The two 
components, however, have different roles in artery: elastin is mainly located in large arteries, it 
maintains the strength of vessels at lower pressures [115]. With elastin, large artery is responsible for 
buffering the flow and pressure variation generated by the intermittent ventricular contraction and 
converting the pulsatile variation into constant forward blood flow to peripheral tissues [82,115]. 
Collagen fibres, on the other hand, are located mainly in medium and small sized muscular arteries; it 
bears most of the strength at the higher pressures [82,115]. 
The balance of production and degradation of collagen and elastin depends on the regulation of matrix 
metalloproteases (MMPs) and its inhibitors [8,118]. Notably, inflammatory cells produce MMPs, 
which leads to the deposition of abnormal collagen and reduction in elastin [8,118]. Advanced 
glycation end products (AGEs), another prominent feature of CKD, particularly in patients with 
diabetic nephropathy or those receiving PD, is another contributing factor [8]. AGE could be linked to 
collagen and result in the accumulation of abnormal collagen molecules, which is stiffer and less 
susceptible to hydrolytic turnover; while AGE linking to elastin fibers reduces the elasticity of the wall 
[8’ 118,119]. In addition, AGE directly stimulates inflammatory responses, which could trigger MMP 
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production and impair endothelial function [8, 118,119], resulting in a vicious circle. 
1.7.5 Arterial stiffness and renal function 
The relationship between arterial stiffness and renal function has been studied widely. For example, a 
recent study [120] in Japanese patients found a negative relationship between estimated glomerular 
filtration rate and arterial pulse wave velocity (PWV) (an indicator of arterial stiffness), indicating that 
arterial stiffness progressively increases with renal function deterioration. Similarly, Schillaci G [121] 
also showed that estimated GFR was inversely related to both central and peripheral arterial stiffness, 
and the association remained statistically significant after adjusting for potential confounding factors 
such as age, sex, distending pressure, and other major cardiovascular risk factors. Reduced kidney 
function may cause increased arterial stiffness by increasing in the calcium content of the arterial wall, 
endothelial dysfunction, activation of the renin angiotensin aldosterone system, qualitative and 
quantitative changes in the arterial wall (such as advanced glycation end product deposition, lipid 
peroxidation, elastin fragmentation, vascular smooth muscle cell hyperplasia) [121]. 
On the other hand, arterial stiffness may affect kidney function. Kidney itself is a major target of 
atherosclerosis [64,120]. Glomerular capillaries are potentially damaged by increased arterial stiffness 
as a result of exposure to high pulse pressure, which would lead to increased myogenic tone of 
afferent arterioles [121]. 
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1.7.6 Arterial stiffness in PD 
The phenomenon of arterial stiffness has been specifically studied in PD patients. Stompor et al [122] 
found in multiple regression analysis that age and systolic BP were related to augmented arterial 
stiffness as measured by PWV. In this study, plasma basic fibroblast growth factor levels also were 
associated independently with reduced arterial compliance. Konings et al [123] found that the 
distensibility coefficient of the common carotid artery in PD patients is significantly less than in the 
nonrenal population. Furthermore, carotid distensibility in PD patients in this study was better than in 
hemodialysis patients and even in predialysis patients with chronic renal failure. On the other hand, 
Co vie et al [124] analyzed arterial function in patients dialyzed using different modalities of renal 
replacement therapy and found that PD patients had a greater PWV and augmentation index as 
compared to hemodialysis patients. In this study, endothelial dependent and endothelial-independent 
vascular function was more blunted in PD patients compared with patients with ESRD treated with 
hemodialysis. Taken together, data comparing the arterial stiffness in PD and hemodialysis patients 
remain inconclusive. 
1.7.7 Arterial stiffness and clinical outcome 
Parameters of arterial stiffness have been associated significantly with cardiovascular morbidity and 
mortality in patients with essential hypertension. In the studies by Boutouyrieet al [125] and Weber et 
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al [126], aortic stiffness is an independent predictor of primary coronary events in these patients. 
Furthermore, increased PWV (over 13 m/s) is a potent and independent predictor of cardiovascular 
death in hypertensive patients without clinically evident atherosclerosis. In another study by Blacher et 
al [127], the augmentation index (another marker of aortic stiffness, see below) is also a strong 
predictor of premature coronary artery disease in the nonrenal population. In this study, the odds ratio 
for being in a high cardiovascular mortality risk group (i.e. over 5% for 10 years) for patients in the 
upper quartile of PWV was 7.1. These findings were confirmed by other studies and are true even for 
normotensive elderly individuals without renal impairment [128]. 
In patients with ESRD, Blacher et al [129] showed that for any increase in PWV index (measured 
PWV minus theoretical PWV determined by means of ultrasonography) by 1 m/s, there was a 14% 
increase in adjusted cardiovascular and overall mortality. In another cohort study of 180 dialysis 
patients followed up for 52 months, Safar et al [130] investigated carotid pulse pressure by means of 
applanation tonometry and aortic PWV by means of Doppler ultrasonography. In this study, aortic 
PWV was a strong predictor of all-cause and cardiovascular mortality. 
The effect of increased arterial stiffness on cardiovascular mortality is particularly strong. For example, 
Shoji et al [131] compared patients with ESRD with and without diabetes. Kaplan-Meier analysis 
showed greater all-cause and cardiovascular mortality rates in renal patients with a greater PWV, 
irrespective to the diabetes status. More importantly, when aortic PWV was included as a covariate in 
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the analysis, the impact of diabetes on survival was no longer significant, whereas PWV was a 
significant predictor of cardiovascular and overall death. 
Stenvinkel et al [132] introduced the conception of malnutrition inflammation atherosclerosis (MIA) 
syndrome. Recent studies showed a direct relationship between inflammation and arterial stiffness in 
PD patients [133]. Blood vessels were stiffer in malnourished patients than those in well-nourished 
subjects [134]. 
MIA syndrome is not only a clinical observation but is associated with high mortality rate [117,135]. 
A previous study [64] showed that intima-media thickness, CRP (an indicator of inflammation) and 
serum albumin were independent predictors of cardiovascular death in patients with ESRD. It has been 
speculated that suppression of the vicious cycle of MIA would improve survival in ESRD patients. 
Assessment of the presence of MIA syndrome may help the selection of the modality of renal 
replacement therapy in ESRD patients [136]. 
1.7.8 Assessment of arterial stiffness 
Several parameters of arterial stiffness have been investigated (Table 1-3). Two of these, derived from 
the application of applanation tonometry, have emerged as particularly valuable: pulse wave velocity 
(PWV) and the augmentation index (AI). These two measurements have the advantages of being 
simple methods of calculation and measurement, providing reproducible values, and have 
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prospectively validated prognostic significance, 
PWV is greater in stiffer arteries and is clearly associated with increased mortality in both the renal 
and nonrenal populations. The Al also is clearly associated with patient survival; Al represents the 
difference between the first and second systolic peak of the pulse wave contour divided by PP height, 
Al is a composite parameter because it reflects the reflective properties of the peripheral distal arterial 
bed and elastic properties of large arteries. Thus, these 2 measures, although correlated, are not 




































































































































































































































































































































































































































































































































































































































































































































Ultrasound measurements using expensive equipment in vascular laboratories (e.g, high resolution 
echo-tracking systems) have led to the development of several dynamic indices for arterial stiffness, 
more useful for research studies than for recurrent clinical evaluations. The most prominent of these is 
the incremental elastic modulus, usually measured in the common carotid artery. Incremental elastic 
modulus is the slope of the relationship between stress and strain of arterial vessels and is calculated 
by transcutaneous measurements of common carotid internal diameter, wall thickness, and carotid PP. 
Common carotid compliance and distensibility (the distensibility coefficient and stiffness parameter) 
are determined from changes in carotid artery diameter during systole and simultaneously measured 
carotid PP. 
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1.8 An overall construct 
From the above discussion, it is clear that chronic fluid overload, high peritoneal transport, and 
increased arterial stiffness are all common in PD patients, related to their adverse clinical outcome, 
and closely interlinked. Based on the literature reviewed previously, it seems very possible that high 
peritoneal transport is a major cause of fluid overload in PD patients, and vascular dysfunction may 
directly contribute to peritoneal transport status. This theoretical construct, which has not been 




































































































































































































We hypothesize that chronic systemic fluid overload is a predictor of mortality and morbidity of 
peritoneal dialysis patients, and the degree of fluid overload correlates with peritoneal transport status 
as well as the degree of arterial stiffness. 
The objectives of this series of work are, therefore: 
a) To study the relationship between radiographic markers of intravascular volume status and the 
clinical outcome in a cohort of prevalent PD patients. 
b) To study the internal relationship between radiographic measurements of intravascular volume 
status, arterial pulse wave velocity and peritoneal transport characteristics, and explore whether 
these parameters are prognostic indictors of PD patients. 
63 
CHAPTER 2 - GENERAL METHODOLOGY 
2. 1 Radiographic Parameters of Intravascular Volume Status 
Vascular pedicle width (VPW) and cardiothoracic ratio (CTR) were used in this series of work because 
they have been identified as noninvasive surrogate markers of intravascular volume status [77]. The 
method of VPW and CTR has been well described. Briefly, postero-anterior chest radiographs were 
obtained. All radiographic examinations were performed with computed radiography equipment 
(Mobilett Plus, Siemens Medical Solutions Malvern, PA) using a standardized technique (75 kV, 4 
mAs, 180-cm film-focus distance; broad tube focus). The images were assessed using a PACS 
(Magicview, model VA22E, Siemens Medical Solutions) viewer (2K monitor). 
VPW is defined as the mediastinal silhouette of the great vessels [77] and is illustrated in Fig2-1. 
Briefly, the right border of VPW is defined as the point that superior vena cava crosses the right main 
bronchus. The left border is the point of subclavian artery exiting from aorta. The VPW was defined as 
the horizontal distance measured between the two points. Previous studies showed that the normal 
range of VPW is 48 土 5 mm. in western populations [77,78]. 
CTR is also determined from the same chest radiograph film. Fig 2-2 showed the measurement of 
CTR. We followed the method described by Edward F et al [137] and defined the midline as a vertical 
line drawn through the spinous processes. The maximum distance from the midline to the right cardiac 
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border (A) was added to the maximum distance from the midline to the left cardiac border (B). This 
sum was divided by 2 times the widest transverse radius of the thorax (C). In other words, CTR = (A+ 
B ) / 2 x C . 
Both VPW and CTR are the indicators of intra-vascular volume status; however, VPW emphasizes the 
changes in the mediastinal silhouette of the great vessels and CTR focuses on the changes of heart 
volume. 
VPW and CTR were performed by one observer and the intra-observer coefficient of variation, 
according to the following formula: 
Mean difference of VPW/ CTR = (Y^ Difference of VPW/CTR between two measure times within one 
sample) + The total number of sample 
Mean VPW/CTR =广 X Mean VPW/CTR of two measure times within one sample)— The total number of 
sample 
Observation variation (%) = Mean difference of VPW/CTR + Mean VPW/CTR 
In our study, the inter- and intra-observer coefficient of variations were 2.9% and 6.1%, respectively. 
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Figure 2-1 Measurement of vascular pedicle width (VPW) 
IT 
The right border of VPW is the point that superior vena cava 
crosses the right main bronchus. The left border is the point of 
subclavian artery exiting from aorta. The VPW was defined as the 
horizontal distance measured between the two points. 
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Figure 2-2 Measurement of cardiothoracic ratio (CTR) 
mm 
匪 
The right border of VPW is the point that superior vena cava 
crosses the right main bronchus. The left border is the point of 
subclavian artery exiting from aorta. The VPW was defined as the 
horizontal distance measured between the two points. 
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2.2 Pulse Wave Velocity Study 
The analysis of PWV depends on Complior® SP program (Artech Medical, France) to calculate pulse 
wave propagation velocity. With this system, the operator is able to visualize the shape of the recorded 
arterial waves and to validate the findings [138]. This device commonly uses three (carotid, radial, 
femoral) piezoelectric pressure sensors for simultaneous arterial waveform measurement. The sensors 
allow for measurement of PWV at various arterial segments: carotid-femoral (aortic stiffness), 
carotid-radial (upper extremity arterial stiffness), and brachial-radial (forearm arterial stiffness). In 
addition, estimated central aortic pulse pressure and an arterial stiffness index are measured. The small 
device connects to a computer and uses a USB port for its power source [139,140]. 
Patients were in supine position; piezoelectric pressure sensors were usually put on the right common 
carotid artery, right radial and right femoral artery. PWV of the carotid-femoral (C-F PWV) and 
carotid-radial (C-R PWV) territory are calculated as PWV = D (meters)/1 (seconds). The distance (D) 
covered by the waves is usually the surface distance between the two recording sites. When measuring 
the distance of carotid to femoral, three methods were recommend (i) using the total distance between 
the carotid and femoral sites of measurement or (ii) subtracting the distance from the carotid location 
to the sternal notch from the total distance or (iii) subtracting the distance from the carotid location to 
the sternal notch from the distance between the sternal notch and the femoral site of measurement 
[138]. In our study, we adopted (ii). Abdominal obesity, particularly in men, and large bust size in 
women can make distance measurements inaccurate [138]. In order to improve the accuracy, we often 
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put a pencil perpendicularly on the femoral artery to ensure the tapeline can go through smoothly 
without obstacle of big belly or bust. The time delay (transit time) is measured between the feet of the 
two waveforms, the transit time is determined by means of a correlation algorithm between each 
simultaneous recorded wave [77 82，138] For example, as illustrated in Figure 2-3, the carotid-femoral 
pulse wave velocity could be calculated as AL + At. 
There is no unanimous normal range of PWV, because several factors (age, blood pressure, DM) can 
affect PWV. According to DeLoach SS et al [139]，a typical aortic PWV in healthy 20-yr-old is 
approximately 4.5 m/s. A typical brachial PWV in the same person would be 9 m/s. When that person 
reaches 70 yr and remains in good health, the aortic velocity will have risen to approximately 10 to 11 
m/s (2.5-fold increase), whereas the brachial velocity will be approximately 11 to 12 m/s (1.3-fold 
increase). The change in PWV in the aorta from aging and various comorbidities is greater than the 
change in PWV in muscular artery circuits such as the brachial or the femorotibial. 
Similar to VPW and CTR, PWV was performed by one observer and the intra-observer coefficient of 
































































































































































2.3 Dialysis adequacy study 
The total Kt/V was determined according to the Dialysis Outcomes Quality Initiative (K-DOQI) 
guideline [141]. Briefly, we used the following equation: 
weekly urinary urea clearance (L/week) = urinary urea concentration (mmol/1) 
X total daily urinary volume (L/day) + plasma urea concentration (mmol/1) x 7 
To determine total Kt/V，the whole body urea distribution space must first be determined. The latter 
was generally estimated by the total body water (V)，which could be calculated by the Watson's 
formula: 
V (L) (male) = 2.447 一 [0.09156 x age (year) ] + [ 10.74 x height (m) ] + [ 0.3362 x weight (kg)] 
V (L) (female) = -2.097 + [10.69 x height (m) ] + [ 0.2466 x weight (kg)] 
Residual renal function was represented by the residual glomerular filtration rate (GFR). Residual 
GFR was calculated as the average of 24-hour urinary urea and creatinine clearance [142], as 
represented by the following equation: 
Residual GFR (ml/min) = [Daily renal creatinine clearance (L/day) + Daily renal urea clearance 
(L/day)]+ 2 + 1.4 
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2.4 Peritoneal equilibration test (PET) 
In this series of work, PET is performed by the standard PET as described by Twardowski, using a 4 h 
dwell with a 2.27% glucose dialysis solution [143]. The protocol of PET is enclosed. All patients were 
in euvolemic state during PET. Drainage and ultrafiltration volumes (UF) at 4 hour were documented. 
Briefly, dialysate creatinine and glucose levels at 0，2 and 4 hours, plasma creatinine and glucose 
levels at 2 hour were measured. Drainage volume at 4 hour was documented. Creatinine 
concentration in dialysate was corrected according to a formula validated in our laboratory. The 
dialysate-to-plasma ratio of creatinine (D/Pcreat) at 0，2，and 4 hours were calculated after correction 
of glucose interference [143]; and the dialysate-to-initial dialysate ratio of glucose (Dt/DO) are also 
calculated. Mass transfer area coefficients of creatinine (MTAC) normalized for body surface area 
(BSA) was calculated by the formula described by Krediet [144]. BSA was determined from body 
weight and height by a nomogram. The results of PET were plotted on a PET graph, and patients were 
classified into high, high-average, low-average and low transporter [145]. 
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Prince of Wales Hospital Renal Unit Peritoneal Equilibration Test (PET) 
The patient for PET should be put on CAPD for at least one month and is free from peritonitis for at least one 
month. 
Remind the patient do not have bag exchange at home in the morning of PET. 
Inform the patient for PET that he/ she will have to stay in hospital for the whole morning (about 5 hours). 
Step-by-step test procedure 
• The patient performs a usual CAPD bag exchange for 8-12 hour over-night dwell prior to the day of PET. 
• The patient arrives at renal unit at 7-8 a.m. for PET. 
• Measure the patient's body weight and body height. 
At 0 hour 
1. With the patient up-right, drain overnight dwell fluid over 20 minutes and record volume drained. 
2. 2 liters of 2.5% dialysate is infused at a rate of 200ml/min. The patient should roll from side to side after 
each 400ml of solution is infused for better mixing of the infused fluid. 
3. As inflow complete, drain 200ml of dialysate out into the bag and then infuse back into the peritoneal cavity. 
4. Drain 200ml of dialysate out into the bag immediately after completion of step 3. 
5. Mix the 200ml of dialysate well, 
6. Collect 20ml of the drained dialysate from the injection port with aseptic technique. 
7. Send 10ml of the specimen for sugar, urea and creatinine. (0 dwell time) 
8. Infuse the remaining 180 ml dialysate back into the peritoneal cavity. 
9. Patient is ambulatory after step 8. 
At 2 hour dwell 
1. Take a blood sample for sugar, urea and creatinine (5 ml). 
2. Drain 200ml of dialysate into the bag and then infuse back into peritoneal cavity. 
3. Drain 200ml of dialysate out into the bag immediately after completion of step 2. 
4. Mix the 200ml of dialysate well. 
5. Collect 10ml of the drained dialysate from the injection port with aseptic technique. 
6. Send the specimen for sugar, urea and creatinine. (2 hour dwell time) 
7. Infuse the remaining 190 ml dialysate back into the peritoneal cavity. 
8. Patient is ambulatory after step 7. 
At 4 hour dwell 
1. Drain the dialysate completely with the patient in sitting position. The patient can do a bag exchange 
according to his/ her usual regimen. 
2. Measure volume of the drained dialysate. 
3. Mix the effluent thoroughly. 
4. Collect 20ml of the drained dialysate from the injection port with aseptic technique. 
5. Send 10 ml of the specimen for sugar, urea and creatinine. (4 hour dwell time) 
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2.5 Assessment of nutritional status 
Nutritional status was assessed by subjective global assessment (SGA), Malnutrition-Inflammation 
Score (MIS), normalized protein nitrogen appearance (NPNA) and fat-free edema-free body mass 
(FEBM). For SGA, the 4-item 7-point system was used [146, 147]. The four items for assessment 
were change in body weight, the degree of anorexia, the amount of subcutaneous tissue and muscle 
mass. The four individual item scores were then combined to generate a global score, which also took 
into account the clinical judgment of the observers and thus did not represent the simple arithmetic 
aggregate of the four individual item scores. All SGA items were rated subjectively on a scale from 1 
to 7，where 1 or 2 is severe malnutrition, 3 to 5 is moderate to mild malnutrition and 6 or 7 is mild 
malnutrition to normal nutritional status [146]. Our previous study showed that the Cohen's kappa 
concordant coefficient for agreement between the observers was 0.84 [147], which was an excellent 
level of agreement. 
The calculation of MIS has been described previously [148]. Briefly, MIS is a score which incorporate 
the SGA and three other components. MIS consists of 4 main parts: patient's related medical history, 
physical examination, body mass index, and laboratory parameters. Patients' medical history includes 
weight changes, dietary intake, gastrointestinal symptoms, functional capacity, comorbidity including 
number of years on dialysis. Physical examination is to detect loss of subcutaneous fat and signs of 
muscle wasting. Laboratory parameters are serum albumin and serum TIBC levels. Serum albumin 
75 
was measured by bromcresol purple method. These 10 components are scored from 0 (normal) to 3 
(very severe), thus the total score ranges from 0 to 30. 
Protein nitrogen appearance (PNA) was measured by creatinine kinetic with 24-hour dialysate and 
urine collections and calculated by the Randerson's equation [149]. Normalized protein nitrogen 
appearance (NPNA) was determined by normalizing PNA with standard body weight. Standard body 
weight was determined according to the recommendation by the DOQI guideline [146]: 
Standard body weight (kg) = total body water (L) + 0.58 
Fat-free edema-free body mass (FEBM) is also measured by creatinine kinetic with 24-hour dialysate 
and urine collections. FEBM is calculated according to the formula described by Forbes and Brunining 
[150] normalised by the desired body weight. Desired body weight was determined by the body height 
and sex according to a standard formula validated in Southern Chinese [151]: 
Desired body weight (kg) (male) = 62 + [(BH (m) - 1 . 7 ) x 60] 
Desired body weight (kg) (female) = 52 + [(BH (m) - 1.58) x 50] 
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CHAPTER 3 一Radiographic Parameters of Intravascular Volume Status as a Prognostic 
Marker in Chinese Peritoneal Dialysis Patients 
3.1 Introduction 
As reviewed in the previous chapters, cardiovascular disease is the major cause of mortality and 
morbidity in PD patients [152, 153], while chronic intravascular hypervolemia has been implicated as 
an important contributing factor of cardiovascular disease [50, 67]. Unfortunately, there is no simple 
and reliable method for the evaluation of volume status in PD patients [154]. Recently, measurement 
of vascular pedicle width (VPW) in chest radiograph (CXR) was found to be a reliable non-invasive 
surrogate marker of intravascular volume status in critically ill patients [77-79]. However, the utility of 
VPW as a surrogate marker of intravascular volume status in PD patients has not been studied. 
In our center, CXR is performed yearly for all stable PD patients for screening of pulmonary 
tuberculosis. This policy provides an excellent opportunity for us to explore the relationship between 
radiographic measurements in routine CXR and the clinical outcome of PD patients. In this study, we 
explore whether a cross-sectional measurement of VPW and CTR from routine CXR are prognostic 
indicator of PD patients. 
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3.2 Patients and Methods 
3.2.1 Patient selection 
We studied 286 prevalent patients who received peritoneal dialysis in our unit in January 2006 and had 
a CXR performed during that time. In all patients, CXR was performed during a routine clinic visit 
without clinical feature of gross fluid overload or overt heart failure. 
Baseline data included age, sex, body height, weight, blood pressure, hepatitis status, history of 
diabetes mellitus (DM), cerebrovascular disease, ischemic heart disease, peripheral disease, underlying 
renal disease, duration on dialysis; baseline blood biochemistry and medication were recorded by chart 
review. The overall burden of comorbidity conditions was quantified by the modified Charlson 
Comorbidity Index, which was validated in PD patients [155]. 
3.2.2 Measurement of VPW and CTR 
In all patients, postero-anterior chest radiographs were obtained. We measure VPW and CTR 
according to the method described in Chapter 2. To adjust the VPW for body size of a patient, we also 
calculated the ratio of VPW dividing by the widest transverse diameter of the thorax (VPWR), 
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3.2.3 Dialysis Adequacy and Nutritional Assessment 
Dialysis adequacy was determined by 24-hour dialysate and urine collection, with weekly Kt/V and 
residual glomerular filtration rate (GFR) calculated. Nutritional status was assessed by Subjective 
Global Assessment (SGA), malnutrition inflammation score (MIS), normalized protein nitrogen 
appearance (NPNA), fat-free edema-free body mass (FEBM), and serum albumin level [156]. The 
methods of their determination are described in Chapter 3. 
3.2.4 Outcome measures 
After the chest radiograph, all patients were followed for up to one year. We determined the actuarial 
patient survival, technique survival, and duration of hospitalization in one year. Transplantation, 
conversion to hemodialysis, or transferring to other units was considered as censored data for actuarial 
survival. The definition of technique survival was patients who were alive and remained on PD. 
3.2.5 Statistical analysis 
Statistical analysis was performed by SPSS 13.0 for Windows software (SPSS Inc., Chicago, IL). 
Results were presented as mean 土 SD unless otherwise stated. Comparisons between groups were 
performed by the unpaired Student's t test. Correlations were expressed by Pearson's or Spearman's 
correlation coefficient, as appropriate. A P-value of < 0.05 was considered as statistically significant. 
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All probabilities were two-tailed. 
Survival rates were analyzed using Kaplan-Meier survival curve. CTR was classified into group I 
(less than or equal to 0.5) and group II (greater than 0.5). The Cox proportional hazards model was 
used to identify independent predictors of actuarial and technique survival [153]. In addition to CTR, 
other independent variables for model construction included age, sex, body weight, mean of blood 
pressure, diabetes mellitus, Charlson's comorbidity score, SGA overall score, malnutrtion 
inflammation score, serum albumin hemoglobin, total cholesterol, Kt/V, and residual GFR. Backward 
stepwise elimination was applied to remove the insignificant variables. 
Multivariate regression analysis was used to analyze hospitalization. Since the data of hospitalization 
were highly skewed, a log-linear regression model was used for analysis. The independent variables 
used for analysis were the same as those for survival analysis. 
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3.3 Results 
3.3.1 General Description 
There were 286 patients studied. The baseline demographic and clinical characteristics were 
summarized in Table 3-1; biochemical, nutritional and dialysis adequacy indices were summarized in 
Table 3-2. The mean VPW was 47.31 士 4.73 mm, CTR was 0.542 士 0.074’ and VPWR was 0.170 士 
0.024. 
3.3.2 Relation with baseline characteristics 
There was a strong correlation between VPW and body weight (Pearson's r = 0.371; p < 0.001) and 
body height (r = 0.271; p < 0.001). VPW also had modest but significant correlation with age (r = 
0.143; p = 0.016) and Charlson's score (r = 0.153; p = 0.01). After adjusting for the thoracic diameter, 
VPWR significantly correlated with age (r = 0.283; p < 0.001)，Charlson's score (r = 0.291; p < 0.001) 
and malnutrition inflammation score (r = 0.191, p < 0.001). VPWR negatively correlated with body 
height (r = -0.151, p = 0.011). VPWR was significantly higher in patients with a history of ischemic 
heart disease (0.177 vs 0.169，p = 0.025), or cerebrovascular accident (0.179 vs 0.168, p = 0.003), or 
peripheral vascular disease (0.185 vs 0.169, p = 0.02) than those without. 
In contrast, the conventional CTR positively correlated with patients' age (r = 0.292, p < 0.001), 
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Charlson's score (r = 0.228, p < 0.001)，malnutrition inflammation score (r = 0.294，p < 0.001) and 
inversely with body height (r = -0.299，p < 0.001)，overall SGA (r = -0.243, p < 0.001), hemoglobin (r 
=-0.289，p < 0.001), serum albumin (r = -0.180, p =0.03), total cholesterol (r = -0.125, p = 0.036), 
total Kt/V (r = -0.192, p = 0.001) and residual GFR (r = -0.352，p < 0.001). Similar to VPWR, CTR 
was higher in patients with ischemic heart disease (0.566 vs 0.537, p = 0.01)，cerebrovascular accident 
(0.561 vs 0.538，p = 0.048), or peripheral vascular disease (0.582 vs 0.540, p = 0.045) than those 
without. 
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Table 3-1. Baseline clinical and demographic characteristics 
No. of patients 286 
Sex (M:F) 147:139 
Age (year) 60.0 士 12.2 
Body height (m) 1.60 土 0.08 
Body weight (kg) 59.9 土 11.2 
Blood pressure (mmHg) 
Systolic 144.1 士 24.4 
Diastolic 75.9 士 14.4 
Renal diagnosis, no. of case (%) 
Glomerulonephritis 81 (28.3%) 
Diabetic nephropathy 81 (28.3%) 
Polycystic kidney 8 (2.7%) 
Hypertensive nephrosclerosis 28 (9.8%) 
Obstructive uropathy 18 (6.3%) 
Others / unknown 63 (22.0%) 
Major comorbidity, no. of case (%) 
Diabetes 113(40.0%) 
Cerebrovascular accident 51 (17.8%) 
Peripheral vascular disease 13 (4.5%) 
Ischemic heart disease 52 (18.2%) 
Charlson's comorbidity score 5.3 土 2.2 
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Table 3-2. Baseline biochemical, nutritional and dialysis adequacy indices. 
No. of patients 286 
Malnutrtion inflammation score 7.39 士 3.2 
Subjective Global Assessment 
overall score 5.6 0 士 0.84 
body weight 5.98 ±1.01 
anorexia 5.62 士 1.06 
muscle mass 5.26 士 1.11 
subcutaneous fat 5.32 士 0.95 
Hemoglobin (g/dL) 8.99 士 1.67 
Total cholesterol (mmol/1) 4.90 土 1.66 
Triglyceride (mmol/1) 1.85 士 1.50 
LDL cholesterol (mmol/1) 2.69 士 1.17 
HDL cholesterol (mmol/1) 1.38 土 0.59 
D/P at 4 hours ‘ 0.642 士 0.135 
MTAC creatinine (ml/min/1.73m2) 9.87 士 4.74 
Serum albumin (g/L) 34.4 土 4.6 
Total Kt/V 2.00 士 0.46 
residual GFR (ml/min/1.73m2) 2.05 ±2.14 
NPNA (g/kg/day) 1.14 土 0.24 
FEBM (%) 52.7 士 14.0 
NB. HDL, high density lipoprotein; LDL, low density lipoprotein; D/P, dialysate-to-plasma 
concentration ratio of creatinine; MTAC, mass transfer area coefficient; GFR, glomerular filtration rate; 
NPNA, normalized protein nitrogen appearance; FEBM, fat-free edema-free body mass by creatinine 
kinetics. 
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3.3.3 Relation with survival 
During the one year study period, there were 36 deaths; 11 patients had kidney transplants, 3 changed 
to hemodialysis, and 3 moved to other units. The causes of death were myocardial infaraction (8 cases), 
cerebrovascular disease (6 cases), peritonitis (6 cases), nonperitonitis infection (6 cases), malignancy 
(4 cases), others or unknown (6 cases). Actuarial patient survival rate in one year was 87.8% and 
technique survival rate was 82.2%. At 12 months, the actuarial survival was 93.3% and, 85.9% for 
CTR groups I and II’ respectively (log rank test, p = 0.075) (Figure 3-1). Similarly, the technique 
survival was 86.5% and 80.7% for CTR groups I and II，respectively (log rank test, p = 0.228) (Figure 
3-2). By multivariate analysis with the Cox proportional hazard model to adjust for confounders, the 
independent factors of actuarial survival were serum albumin and malnutrtion inflammation score; 
independent predictors of technique survival were residual GFR, serum albumin. After adjusting for 
confounding factors, CTR had no independent effect on actuarial or technique survival (p = 0.191 for 
actuarial survival; p = 0.635 for technique survival). Neither VPW nor VPWR affected actuarial (p = 






































































































































































































































































































































































S.3.4 Relation with hospitalization 
There were 4525 days of hospitalization during the study period. Both CTR and VPWR significantly 
correlated with the duration of hospitalization (Spearman's r = 0.192 and 0.186 respectively, p = 0.001 
and 0.002 respectively). In contrast, VPW did not have significant correlation with the duration of 
hospitalization (Spearman's r = 0.039, p = 0.517). Multivariate regression analysis by the log-linear 
modelling showed that independent predictors of hospitalization were VPWR, serum albumin, and 
SGA overall score while CTR did not appear in the final model. The result of the log-linear model was 
summarized in Table 3-3. Relative risk of individual hospitalization predictor was expressed as 
exponential coefficient 
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SGA overall score 
NB. eCOEF was the exponential coefficient indicating the relative time hospitalized (in terms of days) 
compared to the alternative within the variable. For continuous variables, the alternatives were 1% 
lower in VPWR, 1 g/L lower in serum albumin, and 1 point lower in SGA overall score. 
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3.4 Conclusion 
In conclusion, we found that in Chinese PD patients, VPWR and CTR in routine chest radiograph 
were related to patients' age, comorbidity, degree of malnutrition / inflammation, and history of 
cardiovascular diseases; VPWR may correlate with the duration of hospitalization in the subsequent 
one year. 
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CHAPTER 4 - Longitudinal Changes of Radiographic Parameters as the Prognostic Marker of 
Chinese Peritoneal Dialysis Patients 
4.1 Introduction 
The result of the previous study suggests a role of radiographic parameters, either CTR or VPW after 
adjusting for thoracic diameter, as prognostic markers of Chinese PD patients. However, snap-shot 
approach with a single measurement may not be good enough for risk assessment. In fact, the normal 
range of VPW in the literature is derived from western population and, because of the difference in 
body built, may not be applicable to Chinese patients. It seems logical, therefore, to explore whether 
longitudinal change in these radiolographic parameters would provide better prognostic information. 
To the best our knowledge, only one previous study [78] documented the utility of serial VPW 
measurements in critical ill patients. As mentioned previously, chest radiograph is performed yearly 
for all stable PD patients in our center for the screening of pulmonary tuberculosis. This policy 
provides an excellent opportunity to explore the relationship between radiographic measurements in 
routine CXR and the clinical outcome of PD patients. The aim of our next study is to examine whether 
longitudinal changes of VPW and CTR over one year represent prognostic markers of PD patients. 
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4.2 Patients and Methods 
Patient selection 
We enrolled 212 unselected chronic PD patients who were treated for at least 12 months in the dialysis 
unit of Prince of Wales Hospital, Hong Kong. In all patients, CXR was performed between January to 
February 2007 for the assessment of VPW and CTR. Patients with clinical feature of gross fluid 
overload or overt heart failure were excluded. Their CXR 12 months prior to enrollment, which was 
also performed during a routine clinic visit without clinical feature of fluid overload or overt heart 
failure, were retrospectively reviewed. In essence, the patients in this study were survivors from the 
study described in Chapter 4 after one year. Background clinical and biochemical parameter, dialysis 
adequacy and nutritional adequacy indices (see below) were reviewed. All patients were prospectively 
followed for 12 months after enrollment. 
Measurement of VP Wand CTR 
In all patients, two postero-anterior chest radiographs were obtained 12 months apart. The method of 
VPW and CTR measurement has been described in Chapter 2. The changes in VPW (AVPW) and 
CTR (ACTR) in 12 months prior to enrollment were computed. All CXR were analyzed by two 
independent observers for 3 times. The inter- and intra-observer coefficients of variations were 2.9% 
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and 6.1%, respectively. 
Dialysis Adequacy and Nutritional Assessment 
Dialysis adequacy was determined by 24-hour dialysate and urine collection, with weekly Kt/V and 
residual glomerular filtration rate (GFR) calculated. Nutritional status was assessed by Subjective 
Global Assessment (SGA), malnutrition inflammation score (MIS), normalized protein nitrogen 
appearance (NPNA), fat-free edema-free body mass (FEBM), and serum albumin level [156]. 
Outcome measures 
Clinical outcomes included actuarial patient survival, technique survival and number of hospital 
admission in 12 months after enrollment. Transplantation, conversion to hemodialysis, and transferring 
to other units were considered as censored data for actuarial survival. The definition of technique 
survival was patients who were alive and on PD. The cause of hospitalization was divided into three 
parts: cardiovascular diseases (CVD), infection, and other or unknown causes. CVD included 




Statistical analysis was performed by SPSS 13.0 for Windows software (SPSS Inc., Chicago, IL). 
Results were presented as mean 土 SD unless otherwise stated. Comparisons between groups were 
performed by the unpaired Student's t test. Correlations were expressed by Pearson's or Spearman's 
correlation coefficient, as appropriate. A P-value of < 0.05 was considered as statistically significant. 
All probabilities were two-tailed. 
Survival rates were analyzed using Kaplan-Meier survival curve. CTR was divided into three tertiles 
for analysis: CTR tertile I, < 52.1%; II，52.5% to < 60.7%; and III > 60.7%. The Cox proportional 
hazards model was used to identify independent predictors of actuarial and technique survival. In 
addition to the radiological parameters, other independent variables for model construction included 
age, sex, body weight, mean of blood pressure, diabetes mellitus, Charlson's comorbidity score, SGA 
overall score, malnutrtion inflammation score, serum albumin, hemoglobin, total cholesterol, NPNA， 
Kt/V, and residual GFR. Backward stepwise elimination was applied to remove the insignificant 
variables. Cox regression analysis was used to identify independent factors that affect hospitalization. 
Since these data was highly skewed, we determined the time to first hospitalization and data were 
expressed as hospitalization-free survival. The independent variables used for analysis were the same 
as those for survival analysis described above. 
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4.3 Results 
We studied 212 PD patients. The baseline clinical characteristics are listed in Table 4-1. During the 12 
months prior to enrollment, VPW of the patients rose from 53.35 士 5.66 to 55.40 土 6.30 mm (paired 
Student's t test, p <0.001 ); the mean AVPW over 12 months was 2.05 土 4.79 mm. During that 12 
months, CTR rose from 53.3 土 7.1o/o to 56.0 士 7.8o/o (p <0.001); the mean ACTR was 2.64 士 5.64o/o. 
95 
Table 4-1 Baseline clinical characteristics and biochemical profile of the patients. 
Characteristics Value 
Sex (M:F) 97:115 
Age (year) 59.65 土 11.44 
Duration of dialysis (months) 62.9 士 38.0 
Body weight (kg) 59.3 士 11.0 
Body height (m) 1.59 士 0.08 
Renal diagnosis, no. of case (%) 
Glomerulonephritis 63 (28.6%) 
Diabetic nephropathy 54 (24.5%) 
Polycystic kidney 7 (3.2%) 
Hypertensive nephrosclerosis 23 (10.5%) 
Obstructive uropathy 15 (6.8%) 
Others / unknown 46 (20.9%) 
Major comorbidity, no. of case (%) 
Diabetes 81 (38.2%) 
Ischemic heart disease 38 (17.9%) 
Cerebrovascular accident 27 (12.7%) 
Peripheral vascular disease 6 (2.8%) 
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Charlson's comorbidity score 5.16 土 2.13 
Hemoglobin (g/dL) 8.81 士 1.75 
Serum albumin (g/L) 34.72 士 4.05 
Total Kt/V 1.88 士 0.38 
Residual GFR (ml/min/1.73m2) 1.35 土 1.76 
NPNA (g/kg/day) 1.11 土 0.22 
FEBM (%) 55.30 士 13.29 
NB: Residual GFR: residual glomerular filtration rate; NPNA: normalized protein nitrogen 
appearance; FEBM: fat-free edema-free body mass 
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Relation with clinical characteristics 
We found that ACTR negatively correlated with hemoglobin (r = -0.204, p = 0.004), Kt/V (r = -0.249, 
p < 0.001), GFR (r = -0.198，p = 0.005). However, ACTR did not correlate with age, duration of 
dialysis, or blood pressure. AVPW was higher in patients who required hypertonic dialysate in the past 
one year than those who did not (2.86 vs 1.37’ p = 0.026), but it did not correlate any baseline 
biochemical parameter. AVPW correlated with diastolic blood pressure (r = -0.185’ p = 0.017) but not 
systolic one (r = -0.059, p = 0.451). 
Relation with hospitalization 
During the 12 months of follow up, there were 141 (66.5%) patients required admission to hospital, 78 
patients (36.8 %) were admitted to hospital for CVD. At 12 months, the hospitalization-free survival 
were 51.4%, 37.5% and 17.9% for CTR tertile I, II，III respectively (log rank test, p < 0.001) (Figure 
1). By multivariate Cox regression analysis to control for clinical confounders, ACTR (but not 
absolute CTR), mean blood pressure and residual GFR were independent predictor of 
hospitalization-free survival (Table 4-2). In this model, 1% increase in CTR confers 2.9% higher risk 







































































































































































































Table 4-2. Cox proportional hazards model for the first hospital admission. 
Variable AHR 95% CI P value 
ACTR (%) 1.029 1.002- 1.057 p = 0.034 
mean blood pressure (mmHg) 0.979 0.963-0.995 p = 0.010 
residual GFR (ml/min/1.73m^) 0.753 0.641 - 0.883 p < 0.001 
AHR, adjusted hazard ratio; CI, confidence interval; ACTR, change in cardiothoracic ratio in one year; 
GFR, glomerular filtration rate. 
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Relation with patient survival 
During the 12 months of follow up, there were 23 deaths, 1 patient had kidney transplants, 3 changed 
to hemodialysis, 2 moved to other units and 2 termination of dialysis. The causes of death were 
cardiovascular disease (7 cases), peritonitis (6 cases), non-peritonitis infection (6 cases), others or 
unknown (4 cases). Actuarial patient survival rate in one year was 87.7% and technique survival rate 
was 84.7%. The actuarial survival were 90.9%, 89.9% and 81.8 % for tertile I, II, III respectively (log 
rank test, p = 0.247) (Figure 4-2). Similarly, the technique survival were 89.4%, 87.0% and 78.8% for 
tertile I，II, III respectively (log rank test, p =0.238) (Figure 4-3). Serum albumin and NPNA were the 
predictors of actuarial survival; serum albumin was the predictor of technique survival (not shown in 

































































































































































































































































































































































































































































































































































































The main finding in our study is ACTR negatively correlated with hemoglobin, Kt/V，GFR. Besides, 
ACTR is an independent predictor of hospitalization-free survival. This simple radiological parameter 
may serve as an important parameter for the risk stratification of PD patients. 
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CHAPTER 5 — The Relation between Arterial Pulse Wave Velocity, Peritoneal Transport 
Characteristics, and Radiological Parameters of Intravascular Volume Status 
in Chinese peritoneal dialysis patients 
5.1 Introduction 
As reviewed in Chapter 1，chronic fluid overload, high peritoneal transport, and increased arterial 
stiffness are all common in PD patients, related to their adverse clinical outcome, and closely 
interlinked. Based on the literature reviewed previously, it seems very possible that high peritoneal 
transport is a major cause of fluid overload in PD patients, and vascular dysfunction may directly 
contribute to peritoneal transport status. This theoretical construct, however, has not been examined 
previously. The aim of our next study is to find out whether there is any relationship between arterial 
stiffness, peritoneal transport characteristics and intravascular volume status, and whether these 
parameters could predict clinical outcome of peritoneal dialysis patients. 
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5.2 Patients and Methods 
5.2.1 Patient selection 
We enrolled 107 unselected prevalent PD patients in our unit. A plain postero-anterior chest radiograph, 
peritoneal equilibration test, and arterial pulse wave velocity were studied. Background clinical and 
biochemical parameter, dialysis adequacy and nutritional adequacy indices were reviewed (see below). 
5.2.2 Measurement of Chest Radiograph 
In all patients, postero-anterior chest radiographs were obtained. The method of vascular pedicle width 
(VPW) measurement has been described in Chapter 2. 
•5.2 Pulse Wave Velocity Study 
Pulse wave velocity (PWV), an index of aortic stiffness, was measured using an automatic 
computerized recorder and the results are analyzed using the Complior® SP program (Artech Medical, 
France). The method of PWV measurement has been described in Chapter 2 in detail. Briefly, 
pressure-sensitive transducers are placed over the neck (carotid artery), wrist (radial artery) and groin 
(femoral artery) with the patient in the supine position within one week of PET. PWV of the 
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carotid-femoral (C-F PWV) and carotid-radial (C-R PWV) territory were calculated by dividing the 
distance between the sensors by the time corresponding to the period separating the start of the rising 
phase of the carotid pulse wave and that of the femoral and also the radial pulse waves. 
5.2.4 Peritoneal equilibration test (PET) 
We used the standard PET as described by Twardowski [103]. All patients were in euvolemic state 
during PET. The procedure of the test was described in detail in Chapter 2. It should be noted that PET 
and PWV might not be performed on the same day, but they were generally less than 4 weeks apart, 
and both were performed when the patient was clinically euvolemic. 
5.2.5 Dialysis adequacy and nutritional status 
Dialysis adequacy was determined by 24-hour dialysate and urine collection, with weekly Kt/V and 
residual glomerular filtration rate (GFR) calculated. Nutritional status was assessed by Subjective 
Global Assessment (SGA), malnutrition inflammation score (MIS), normalized protein nitrogen 
appearance (NPNA), fat-free edema-free body mass (FEBM), and serum albumin level [157]. 
5.2.6 Outcome measures 
All patients were followed for up to 12 months after recruitment. Clinical outcomes included number 
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of hospitalization for CVD, total number of hospitalization for any cause, duration of hospitalization, 
actuarial patient survival and technique survival. The cause of hospitalization was divided into three 
parts: cardiovascular diseases, infection, and other or unknown causes. CVD included cerebrovascular 
diease, coronary heart disease, congestive heart failure and peripheral vascular disease. 
Transplantation, conversion to hemodialysis, and transferring to other units were considered as 
censored data for actuarial survival. The definition of technique survival was patients who were alive 
and on PD. 
5.2.7 Statistical analysis 
Statistical analysis was performed by SPSS 13.0 for Windows software (SPSS Inc., Chicago, IL). 
Results were presented as mean 土 SD unless otherwise stated. Comparisons between groups were 
performed by the unpaired Student's t test. Correlations were expressed by Pearson's or Spearman's 
correlation coefficient, as appropriate. A P-value of < 0.05 was considered as statistically significant. 
All probabilities were two-tailed. 
Survival rates were analyzed using Kaplan-Meier survival curve. The Cox proportional hazards model 
was used to identify independent predictors of actuarial survival and technique survival. VPW, CTR, 
PWV and baseline variables were added into the model. Backward stepwise elimination was applied to 
remove the insignificant variables. 
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Multivariate regression analysis was used to analyze the duration of hospitalization. Since the data was 
highly skewed, a log-linear regression model was used for analysis. In addition to VPW, CTR, C-R 
PWV, C-F PWV, and D/P creatinine at 4 hours, the models were constructed by age, diabetic status, 
Charlson's comorbidity score, SGA overall score, malnutrtion inflammation score, serum albumin, 
total Kt/V, NPNA, FEBM and residual GFR. These parameters were selected for the construction of 
the models because of their importance in determining the clinical outcome of PD patients according 
to previous studies. 
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5.3 Results 
5.3.1 General Description 
We studied 107 PD patients in total. The baseline clinical characteristics were listed in Table 5-1 and 
baseline biochemical parameters summarized in Table 5-2. The mean VPW was 50.2 土 5.8 mm, CTR 
was 0.54 士 0.06，the mean carotid-femoral PWV (C-F PWV) was 9.93 士 2.11 nVs, carotid-radial PWV 
(C-R PWV) was 9.91 士 1.35 m/s, D/P was 0.57 土 0.14. 
110 
Table 5-1. Baseline clinical characteristics of the patients. 
Variables Value 
Age (year) 57.5 士 14.7 
Sex (M : F) 57: 50 
Body height (m) 1.60 ±8.11 
Body weight (kg) 60.8 士 12.8 
Duration of dialysis (month) 19.8 士 30.9 
SBP (mm Hg) 140 土 26 
DBP (mm Hg) 75.6 士 12.2 
Renal diagnosis, no. of case (%) 
Glomerulonephritis 27 (25.2 %) 
Diabetic nephropathy 38 (35.5 %) 
Polycystic kidney 2 (1.9 %) 
Hypertensive nephrosclerosis 12 (11.2 %) 
Obstructive uropathy 3 (2.8 %) 
Others / unknown 25 (23.4 %) 
Major comorbidity, no. of case (%) 
Diabetes 52 (48.6%) 
Ischemic heart disease 13 (12.1 %) 
Cerebrovascular accident 2 (1.87 %) 
Charlson's comorbidity score 5.00 ± 1.88 
111 
Table 5-2. Baseline biochemical profile of the patients. 
Number of patients 107 
Malnutrtion inflammation score 5.26 ± 3.63 
Subjective Global Assessment 
overall score 5.91 ± 0.78 
body weight 5.96 士 1.04 
anorexia 5.83 士 1.01 
muscle mass 5.85 ± 0.88 
subcutaneous fat ± 0-92 
Hemoglobin (g/dL) 8.90 士 1.16 
Serum albumin (g/L) 34.04 土 4.85 
Lipid profile 
Total cholesterol (mniol/1) 5.05 士 1.53 
Triglyceride (mmol/1) 1-93 土 1-23 
LDL cholesterol (mmol/1) 2.88 土 1.10 
HDL cholesterol (mmol/1) 1.27 ± 0.39 
Total K W 2.12 ±0.60 
residual GFR (ml/min/1.73m2) 3.37 ± 2.74 
NPNA (g/kg/day) 1.09 士 0.26 
FEBM(%) 42.94 ±11.97 
Peritoneal transport 
ultrafiltration (L) 2.39 士 0.23 
D/P creatinine 0.57 土 0.14 
MTAC creatinine (ml/min/1.73m2) 7.47 ±4.11 
NB: SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; Mean BP mean 
arterial pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; D/P, 
dialysate-to-plasma concentration ratio of creatinine; MTAC, mass transfer area coefficient; GFR, 
glomerular filtration rate; NPNA, normalized protein nitrogen appearance; FEBM, fat-free edema-free 
body mass by creatinine kinetics. 
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5.3.2 Relation between Radiographic Measures, Pulse Wave Velocity, Peritoneal Transport, and other 
Baseline Parameters 
There was no relationship between any chest radiograph measure and arterial pulse wave velocity 
(Table 5-3). Peritoneal transport characteristic, as represented by D/P creatinine at 4 hours, also did not 
correlate with VPW (r = -0.001，p = 0.9), CTR (r = 0.146, p = 0.2)，C-R PWV (r = 0.004, p = 0.9)，or 
C-F PWV (r =-0.013’ p = 0.9). 
However, VPW correlated with body height (r = 0.386，p < 0.001), body weight (r = 0.312, p = 0.003) 
and HDL (r = -0.296, p = 0.005). CTR positively correlated with age (r = 0.258, p = 0.014)，body 
height (r = -0.252, p = 0.016)，SBP (r = 0.227’ p = 0.031), PP (r = 0.269, p = 0.01). C-F PWV 
positively correlated with age (r = 0.354, p < 0.001)，SBP (r = 0.429’ p < 0.001)，PP (r = 0.488, p < 
0.001), mean BP (r = 0.318, p = 0.001)，Charlson's comorbidity score (r = 0.587, p < 0.001), total 
cholesterol (r = 0.227, p = 0. 021) and triglyceride (r = 0.480, p < 0.001), and negatively correlated 
with HDL (r = -0.225，p = 0.022). C-R PWV correlated with body height (r = 0.228, p = 0.018)，DBP 
(r = 0.341，p < 0.001) and mean BP (r = 0.247, p = 0.01). D/P positively correlated with malnutrtion 
inflammation score (r = 0.317, p = 0.041), and negatively correlated with serum albumin (r = -0.455, p 
< 0.001)，calcium (r = -0.237, p = 0.021), phosphate (r = -0.255, p = 0.013). 
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Table 5-3. The relationship between radiographic measures and arterial pulse wave velocity. 
radiographic measures 
arterial pulse wave velocity VPW CTR 
C-R PWV r = 0.113，p = 0.287 r = -0.142, p = 0.183 
C-F PWV r = -0.059，p = 0.581 r = 0.115，p = 0.279 
VPW, vascular pedicle width; CTR, cardio-thoracic ratio; C-R PWV, carotid-radial pulse wave 
velocity; C-F PWV, carotid-femoral pulse wave velocity 
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5.3.3 Relation with Hospitalization 
The total duration of follow up was 107 patient 1001 months. There were 1001 days of hospitalization 
during the study period; 56 (52.8 %) patients required admission to hospital, 16 patients (15.1 %) were 
admitted to hospital for CVD. Multivariate regression analysis by the log-linear modelling showed that 
the independent predictors of the number of hospitalization for CVD were C-F PWV and D/P (Table 
5-4A). In contrast, only the Charlson's comorbidity score was an independent predictors of total 
number of hospital admission (Table 5-4B). Relative risk of individual hospitalization predictor was 
expressed as exponential coefficient (e^f). 
115 
Table 5-4. Summary of log-linear regression models for independent predictors of number of 
hospitalization. 
(A) Hospitalization for cardiovascular disease 
Variable e^® '^' P value 
C-F PWV 1.74 P = 0.041 
D/P 1.55 P = 0.01 
(B) Hospitalization for all causes 
Variable eCOEF P value 
Charlson's comorbidity score 1.61 P = 0.005 
C-F PWV, carotid-femoral pulse wave velocity; D/P, dialysate-to-plasma concentration ratio of 
creatinine at 4 hours. 
NB. eCOEF was the exponential coefficient indicating the number of admission (in terms of times) 
compared to the alternative within the variable. The alternatives were 1 m/s faster in C-F PWV, 1 unit 
higher in D/P, or 1 point higher in Charlson's comorbidity score. 
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(C) Duration of hospitalization for all causes 
Variable P value 
C-F PWV 0.49 P = 0.001 
Hemoglobin 2.30 P < 0.001 
Kt/v 0.546 P = 0.012 
GFR 0.547 P = 0.008 
NPNA 2.06 P = 0.001 
Charlson's comorbidity score 1.55 P = 0.044 
C-F PWV, carotid-femoral pulse wave velocity; GFR, glomerular filtration rate; NPNA, normalized 
protein nitrogen appearance. 
NB. eCOEF was the exponential coefficient indicating the relative time hospitalized (in terms of days) 
compared to the alternative within the variable. The alternatives were 1 m/s slower in C-F PWV, 1 
g/dL higher in hemoglobin, 1 lower in Kt/v, 1 lower ml/min/1.73m2 in GFR, 1 g/kg/day higher in 
NPNA and 1 point higher in Charlson's comorbidity score. 
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5.3.4 Relation with Mortality 
During the study period, there were 7 deaths; 2 patients had kidney transplant, 1 patient changed to 
hemodialysis, 2 patients transferred to other units. The cause of death were cardiovascular disease (1 
cases), peritonitis (1 cases), non-peritonitis infection (1 cases), others or unknown (4 cases). At 12 
months, actuarial patient survival rate was 91.0% and technique survival rate was 85.8%. By the Cox 
regression model, none of the chest radiograph measures, arterial pulse wave velocity, or peritoneal 
transport characteristics was related to patient survival. 
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5.4 Conclusions 
In this part of our work, we found no relationship between radiological parameters of fluid overload, 
peritoneal transport characteristic, and arterial pulse wave velocity. In the present study, however, both 
C-F PWV and D/P were independent predictors of hospitalization, especially that for CVD. 
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CHAPTER 6 - DISCUSSION 
6.1 Methodology 
Radiological assessment of intravascular volume status 
Many factors can influence the measurement of VPW, thereby reducing its predictive value. For 
example, patient posture plays a significant role; measurement of VPW in the supine position results 
in overestimation by nearly 20% in relation to the position. Rotation of the patient to the right 
increases the VPW, while rotation to the left decreases the measurement. Furthermore, patient height, 
body build, and focal film distance can affect the measurement of true VPW. In this series of work, we 
tried to minimize these alterations by always performing CXR in an upright posture, with non-rotated 
portable CXR taken at a consistent focal film distance. 
In addition to patient positioning and technical factors, it is also possible that disease process or 
respiratory effort might affect the assessment of VPW. Indeed, when components of the silhouette 
have been altered by mediastinal disease, vascular engorgement, or the effects of prior trauma, 
radiation, or thoracic surgery, the utility of the VPW is conceivably compromised. Notably, increased 
VPW may occur in patients with extravascular bleeding, which may be present in patients with 
previous central line insertion (for example, for temporary hemodialysis). In theory, while elevated 
intravascular volume predominantly causes widening to the right of the midline, aortic injury causes 
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widening predominantly to the left of the midline, together with 'vanishing' of the right paratracheal 
stripe and azygous vein. In this series of study, however, we did not attempt to distinguish expansion 
of the right and left side of the vascular pedicle. 
In actual practice, the major difficulty in measuring VPW was to locate the borders of VPW. It was not 
uncommon to find the borders of superior vena cava and subclavian artery blurred, especially when 
the patient had subclinical pulmonary congestion or other chronic lung diseases. In this series of work, 
we tried to minimize the error by measuring VPW two to five times by one (or sometimes two) 
observers. The results of inter- and intra-observer coefficient of variations of our studies were 2.9% 
and 6.1%, respectively), essentially in the acceptable range. 
Assessment of arterial stiffness 
In this series of work, we measure arterial pulse wave velocity as the marker of arterial stiffness. There 
were two major problems we faced while manipulating the PWV machine. First, the piezoelectric 
pressure sensors that were put on the arteries were highly sensitive. As a result, it was difficult to 
obtain a satisfactory signal when the angle and pressure of the sensor changed slightly. Moreover, it 
was difficult for the operator to keep the same posture for a long time in order to minimize any change 
in the sensors. Since it is necessary to put up sensors on both the carotid and femoral artery 
simultaneously, it is often easier to have to operators working at the same time to ensure good signal 
detection. 
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Second, the palpated pulse of carotid and femoral artery might be weak in obese or grossly edematous 
patients, presumably because the pulses were deeply hided under the thick adipose tissue. It was often 
difficult to obtain stable arteroa; waveform on the screen for measurement. Although our studies 
excluded grossly edematous patients, it is important to realize that obesity in itself is a cardiovascular 
risk factor; failure to measure arterial pulse wave velocity from this group of patients might have 
posed a systemic bias in our result. 
Assessment of peritoneal transport and nutritional status 
There is very little dispute on the assessment of peritoneal transport status. In contrast, the ideal 
marker of the nutritional status of PD patient remains controversial. In this series of work, we used 
both subjective and biochemical methods, including SGA, MIS, serum albumin, NPNA, and FEBM. 
Not only is this panel of nutritional indices widely recommended, their prognostic relevance in PD 
patient has been well validated. 
It is important to realize that we did not assess the degree of systemic inflammation (for example, by 
measuring serum level of C-reactive protein or IL-6), which is an important contributor of 
malnutrition and arterial stiffness. Furthermore, we did not directly quantify the degree of 
atherosclerosis (for example, by cardotid intimal thickness) or endothelial dysfunction (for example, 
by brachial artery vasodilation response). As a result, our work did not exclude a possible relation 
122 
between peritoneal transport status and the degree of atherosclerosis or endothelial dysfunction. 
6.2 Results 
Snap-shot measurement of VPW and CTR 
In the first part of our work, we showed that VPWR and CTR were related to patients' age, 
comorbidity, degree of malnutrition / inflammation, and history of cardiovascular diseases. We also 
found that VPWR correlated with the duration of hospitalization in one year, but not actuarial or 
technique survival. 
Our findings were consistent with the general belief about the pathophysiology of fluid overload and 
cardiovascular disease in dialysis patients. Advanced age and the presence of comorbidity conditions 
may expectedly result in excessive intravascular volume, as detected by CTR or VPWR. Both CTR 
and VPWR correlated with malnutrition inflammation score, and patients with history of 
cardiovascular disease (ischemic heart disease, cerebrovascular accident and peripheral disease) had 
higher CTR and VPWR, again supporting the notion that these radiological measurements are 
surrogate markers of underlying cardiovascular diseases. Since residual GFR plays an important role 
in maintaining fluid balance of PD patients [157, 158], it is not surprise that CTR had inverse 
correlation with residual GFR in our study. Since residual GFR and systolic blood pressure correlated 
with CTR but not VPWR, the former may represent a better indicator of intra-vascular volume in PD 
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patients, which is consistent with the previous report by Don et al [159] in hemodialysis patients. It is 
important to note that in our patient population, a direct measurement of VPW without adjusting for 
body size (i.e. thoracic width) seems less useful a clinical marker, probably because of the large 
variation in body built of our patients. 
In this part of the work, VPWR correlated with the duration of hospitalization in one year, indicating 
fluid overload was major reason for hospitalization. Other predictors of hospitalization in our study 
were serum albumin, and SGA overall score, which was in line with current literature. Previous studies 
on VPW, however, focused on its application in critically ill patients [77,78,160]. To the best of our 
knowledge, this is the first study that demonstrates the prognostic value of vascular pedicle width in 
stable subjects and an out-patient setting. For the predictors of actuarial and technique survival, our 
findings were similar with previous studies [50, 153，156]. In our study, neither CTR nor VPWR was a 
predictor of survival, probably because the sample size was small and the follow up was short. In 
addition, the proportion of patients with fluid overload in our study might be low. 
There are other limitations for this study. Firstly, the normal range of VPW reported in literature is 
based on European patients, which may not be applicable to Chinese subjects. As a result, the 
prevalence of high VPW in our PD patients is unknown. Secondly, we have not explored the 
longitudinal changes of VPW and CTR which are expectedly increasing with the loss of residual renal 
function and worsening of systemic atherosclerosis. It remains uncertain whether vigorous dialysis 
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with hypertonic cycles would affect these radiographic measurements. Further research is also needed 
to explore the prognostic role of serial change in VPW and CTR. 
Serial measurement of VP Wand CTR 
In the second part of our work, ACTR negatively correlated with hemoglobin, Kt/V, and baseline 
residual GFR, but not with any nutritional indices (serum albumin, NPNA, or FEBM). In contrast, 
previous study by Chen et al [161] showed that CTR is an indictor of nutritional status in hemodialysis 
patients. Our observation is in line with the conventional wisdom that with a higher Kt/V or residual 
GFR, patients are less likely to have persistent fluid overload and therefore CTR, which represents the 
body fluid status, would tend to decrease [80，161]. On the other hand, body volume and nutritional 
status has been proposed to inter-play with each other [74]. Notably, fluid overload could result in 
gastrointestinal edema, which may lead to anorexia and malnutrition [74,162]. In theory, systemic 
inflammation and loss of residual renal function may each contribute to malnutrition and 
hypoalbuminemia, which possibly precipitates volume overload via a low plasma oncotic pressure. In 
the present study, however, we did not observe any relation between CTR and serum albumin level. 
Another finding was the relationship between AVPW and hypertonic glucose solution. VPW changed 
larger in patients with hypertonic dialysate than without. It can be easily explained that hypertonic 
glucose solution has strong ability to remove much more fluid. It again proved that VPW was the 
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indicator of volume status: fluid accumulation leads to increase in VPW, resulting in a need of more 
hypertonic cycle. However, our study did not show any relationship between A VPW and other 
variables. Since it is not always distinct to locate VPW on CXR，but it is less likely that is the reason 
of undetectable relationship, because our intra-observation variation and inter-observation variation 
were 6.13 %，2.93%, respectively, which were all under 10 %. Further study is needed to be explored. 
In this part of the work, during the 12 months of prospective follow up, ACTR was an independent 
predictor of hospitalization-free survival and number of hospitalization (not shown in detail).. It again 
supported the notion that ACTR reflects the change in intravascular volume status, and it is generally 
accepted that fluid overload was one of the most contributors of CVD [50,163]. Other predictors of 
number of hospitalization-free survival in our study were in line with current literature. For actuarial 
and technique survival, CTR, ACTR, VPW, AVPW were not the predictors, probably because of the 
small sample size and limited statistical power of our study. 
Given the relatively young age and low comorbidity profile of our patient population, the number of 
patients who required hospitalization for CVD appeared quite high. It is important, however, to note 
that we used a loose definition of hospitalization for CVD, and it is often difficult to differentiate 
genuine heart failure from fluid overload secondary to problems of dialysis regimen or dietary 
compliance. Since we performed chest radiograph for all PD patients in our center and we recruited all 
available subjects, the problem of selection bias seems unlikely. The crude mortality of our present 
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study was 10.8%, which was similar to our previous studies [153,164]. It could be estimated that a 
sample size of 4640 would be needed to achieve an 80% power and detect a 30% relative excess in 
mortality. 
Some limitations need to be considered. First, our patients were all in stable status without clinical 
feature of gross fluid overload because peritoneal ultrafiltrate removes excessive fluid, which 
compensates for the loss of residual renal function. So, VPW and CTR did not change too much 
during study period and large variation in body built of our patients, which may disguise some 
significant results (eg. AVPW was not shown to be the predictor of hospitalization). We speculate that 
much more significance would be illustrated if patients were unstable. Second, our study demonstrated 
that it may be necessary to monitor CTR and VPW frequently to monitor volume and nutrition status, 
but we are not sure about the interval between the two monitoring. Furthermore, although there are 
correlations with radiologic parameters (CTR and VPW) and other clinical variables, the correlations 
are often weak, indicating that the radiologic parameters accounted for only a small percentage of 
variation in the clinical variables. In other words, although the correlation coefficients are statistically 
significant, the clinical relevance remains arguable. 
Relation between radiolosic measurement, peritoneal transport, and pulse wave velocity 
In the final part of our work, we found no relationship between radiological parameters of fluid 
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overload, peritoneal transport characteristic, and arterial pulse wave velocity. In the present study, both 
C-F PWV and D/P were independent predictors of the number of hospitalization for CVD. 
Contrary to our prediction, the present study did not show any relationship between arterial pulse wave 
velocity (a marker of arterial stiffness), peritoneal transport characteristic, and radiograph 
measurements (surrogate markers of systemic fluid overload). In contrast, previous studies by Wang et 
al [165, 166] showed a significant relationship between C-F PWV and D/P. The value of C-F PWV in 
their study was 11.1 士 2.3 m/s, which was substantially higher than our cohort (9.93 士 2.11 m/s). We 
are not sure about the exact reason of this discrepancy. It is, however, interesting to note that the 
studies of Wang et al [165, 166] recruited subjects from northern part of China 一 an area of a 
substantially higher dietary sodium intake as compared to our local population. In our center, average 
sodium removal (dialysis plus urinary) of our PD patient was 1.15 ± 1.47 g/day (Szeto CC, 
unpublished data), as compared to 2.3 to 3.2 g/day in PD patients from Beijing [36]. 
In this part of work, we did not find any relationship between peritoneal transport characteristics and 
VPW or CTR. Our result, however, does not imply there is no correlation between high transport and 
fluid overload. A previous study of Konings et al [158] showed that the relationship between 
peritoneal transport and fluid overload was apparent only after a longitudinal study. Besides, a recent 
study of Cheng et al [167] showed there was a negative relationship between volume overload and 
endothelia dysfunction, which was the major site of resistance of peritoneal transport [110,161]. 
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Furthermore, the reliability of VPW or CTR as an indicator of intravascular volume in dialysis patients 
remains to be determined. Average VPW was 50.2 士 5.8 mm in our study, which belonged to the 
normal range according to Ely et al [77], indicating that most of our patients were not in gross fluid 
overload. Nonetheless, the exact normal range of VPW in Asia population was unknown. 
We found that C-F PWV and D/P were independent predictors of hospitalization for CVD. Previous 
study [167] showed transport characteristic was not the predictor of hospitalization. To the best of our 
knowledge, it was the first study to show C-F PWV and D/P were the predictors of hospitalization for 
CVD at the same time. Since there is no internal correlation between these two parameters, our result 
suggests that arterial stiffness, which indicates the severity of atherosclerosis, and high peritoneal 
transport, which predicts fluid overload, each contributes to the development of CVD in this 
population. 
Some limitations of our study need to be noted. First, our patients were all in stable status without 
clinical feature of gross fluid overload. As a result, the percentage of patient with abnormal VPW was 
small, which may disguise any potential relationship. Second, the duration of follow-up time was short, 
and our study certainly does not have the power (both sample size and duration of follow up) to 
ascertain the relationship of pulse wave velocity or peritoneal transport with patient survival. 
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Discrepancies between studies and other problems 
The first two parts of our work showed that VPWR or ACTR was predictor of hospitalization. 
Contrary to these, the third work only showed C-F PWV and D/P were the predictors of 
hospitalization. Neither VPW nor CTR was the predictor. On one hand, the difference in sample size 
may explain such discrepancy. In Chapter 5, we only enrolled 107 patients, which was smaller than the 
first two studies. It was possible that with a larger sample size and prolonged observation period, the 
prognostic value of VPW or CTR may be revealed. On the other hand, we did not assess PWV or 
peritoneal transport assessment during the first two studies. It was also possible that after considering 
these parameters, radiologic measurements would become irrelevant. Taken together, it seems that 
PWV and peritoneal transport status were more influential than radiologic measurements on the 
clinical outcome of PD patients. 
Hospitalization was assessed differently in all three parts. For the first study, we actually analyzed both 
number and duration of hospitalization. The results were more or less the same, so we just showed 
duration of hospitalization. For the second study, the reviewer suggested us analyzed hospital-free 
survival because our study belonged to prospective study. For our third study, we not only explored the 
relationship between the three parameters, but also explored whether these parameters can predict 
CVD. To begin with, we analyzed both number and duration of hospitalization. 
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6.3 Further Directions of Research 
One of our primary objectives was to explore the role of VPW and CTR, which are non-invasive 
assessment of intravascular volume, as prognostic indicator of PD patients. However, we could only 
focus on short term outcome in this series of studies. It would be valuable to examine a larger cohort 
of patients and extend the follow up period so that hard clinical outcomes (for example, cardiovascular 
events and overall mortality) could be studied. Furthermore, research is needed to compare VPW and 
CTR to other measurements of body fluid status (for example, by isotope dilution methods or 
bioimpedance spectroscopy, and to define the normal range of VPW in Chinese patients. 
Another area of further research is related to the complex interaction between peritoneal transport, 
vascular dysfunction, and fluid overload of PD patients. Although our study in Chapter 6 did not 
reveal a significant correlation between peritoneal transport and vascular dysfunction, clinically 
meaningful relation is not excluded. Further research would be needed to compare peritoneal transport 
and the severity of vascular dysfunction as measured by other methods (for example, carotid doppler 
or endothelial function study). Since our result in Chapter 6 also suggest that peritoneal transport is a 
prognostic indicator independent of the severity of fluid overload, further research is needed to clarify 
the mechanism of inferior clinical outcome in patients with high peritoneal transport. 
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6.4 Conclusions 
From this series of work, we conclude that radiographic measurements of intravascular volume status 
from routine chest radiograph are modest prognostic indicators in Chinese PD patients. Neither 
peritoneal transport characteristics nor arterial pulse wave velocity is related to the degree of 
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Abstract 
Background: Volume overload is an important contributing Introduction 
factor of cardiovascular disease (CVD) in peritoneal dialysis … ， … � . , , 
(PD) patients. Vascular pedicle width (VPW) and cardiotho- Cardiovascular disease (CVD) is the leading caus: 
racic ratio (CTR) in routine chest radiograph are indicators of death in peritoneal dialysis (PD) patients [1-4]. Besi 
intravascular volume. Longitudinal changes of VPW and CTR many traditional risk factors, such as hypertension < 
may be important prognostic factors of PD patients. Meth- betes and hyperlipidemia which contribute to C 
od: We studied 212 PD patients. Longitudinal changes in chronic fluid overload probably also plays an imporl 
VPW (AVPW) and CTR (ACTR) were calculated. The relation- part in its pathogenesis. For example, persistent exces 
ship between radiologic measurements and clinical out- intravascular volume may cause remodeling of the a 
come was analyzed. Results: During the 12 months prior to rial structure, which could lead to ventricular hyper 
enrollment. VPW rose from 53.35 ± 5.66to55.40 ± 630 mm phy and increased arterial stiffness [5-7]. 
(p < 0.001) and CTR rose from 53.3 土 7.1 to 56.0 土 7.8% (p < Both overt and subclinical volume overload are， 
0.001). After adjusting for confounding variables by Cox re- common in PD patients [3, 8 9], and it is necessar 
gression model, ACTR is an independent predictor of hos- monitor the volume status of these patients Altho 
pitalization-free survival; 1% increase in CTR confers 2.9% several gold standard tests are available for the as 
higher risk of hospitalization (95% confidence interval ment of intravascular volume [10, 11]，these test 
0.2-5.7%, p = 0.034). None of the radiologic measurements rarely used in clinical practice because they are ti 
correlated with actuarial patient survival. Conclusions: In consuming, invasive, and usually expensive _Rece 
chronic PD patients, ACTR is an independent predictor of measurement of vascular pedicle width (VPW) and 
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diothoracic ratio (CTR) in chest radiograph (CXR) were Serum albumin was measured by bromcresol purple metl. 
found to be valuable non-invasive surrogate markers of NPNA was calculated by the modified Bergstroms formula 
intravascular volume status in critically ill patients [12- U v t h X ^ v t ^ U t ^ f e a l bod二weight，which，determi 
1/11 xr-niAT-i 1 , V •‘. 1 S by the body height and sex according to a standard formu a v 
HJ. VPW has been reported to have a positive correlation dated in Southern Chinese [16]. Adequacy of dialysis was e 
with total blood volume [13, 15]； CTR has been shown to mated by total weekly Kt/V by standard methods [2,4], Resic 
be an indicator of inflammation and nutritional status in glomerular filtration rate (GFR) was calculated as average of 
hemodialysis patients [16]. In our center, CXR is per- l^ our urinary urea and creatinine clearance [21]. All biochem 
formed yearly in all stable PD patients for screening of ； 二 r m e d in our hospital laboratory, which has � 
1 ‘ ' , . . , ^ , t iculous quality control and is accredited as the Area of Med 
pulmonary tuberculosis. This policy provides an excel- Testing by the National Association of Testing Authori 
lent opportunity to explore the relationship between (NATA), Australia, in conjunction with the Royal College of 
radiographic measurements in routine CXR and the din- thologists of Australasia. ‘ � 
ical outcome of PD patients. The aim of this study is to ^ ^ ^ 
examine whether longitudinal changes of VPW and CTR c S u u t Z " included actuarial patient survival, t. 
over 1 year represent prognostic markers of PD patients, nique survival and number of hospital admission in 12 moi 
after enrollment. Transplantation, conversion to hemodial) 
and transferring to other units were considered as censored c 
P a t i e n t s a n d M e t h o d s for actuarial survival. The definition of technique survival 
patients who were alive and on PD. The cause of hospitalizal 
Patient Selection was divided into three parts: CVDs. infection, and other or 
We enrolled 212 unselected chronic PD patients who were known causes. CVDs included cerebrovascular disease, coror 
treated for at least 12 months in the dialysis unit of Prince of Wales heart disease, congestive heart failure and peripheral vasa 
Hospital, Hong Kong. In all patients, CXR was performed be- disease, 
tween January to February 2007 for the assessment of VPW and 
CTR. Patients with a clinical feature of gross fluid overload or Statistical Analysis 
overt heart failure were excluded. Their CXRs 12 months prior to Statistical analysis was performed by SPSS 13.0 for Wind 
enrollment, which was also performed during a routine clinic vis- software (SPSS Inc., Chicago, 111., USA). Results were preset 
it without clinical feature of fluid overload or overt heart failure, as mean ± SD unless otherwise stated. Comparisons bet\~ 
were retrospectively reviewed. Background clinical and biochem- groups were performed by the unpaired Students t test. Corr 
ical parameters, dialysis adequacy and nutritional adequacy indi- tions were expressed by Pearsons or Spearman's correlation o 
ces (see below) were reviewed. All patients were prospectively fol- ficient’ as appropriate. A p value of <0.5 was considered as stz 
lowed for 12 months after enrollment. tically significant. All probabilities were two-tailed. 
Survival rates were analyzed using Kaplan-Meier surv 
Measurement of VPW and CTR curve. CTR was divided into three tertiles for analysis: CTR 
Posteroanterior CXRs were obtained in all patients. All radio- tile I, <52.1%; II，52.5 to <60.7%, and III >60.7%. The Cox \ 
graphic examinations were performed with computed radiogra- portional hazards model was used to identify independent | 
phy equipment (Mobilett Plus, Siemens Medical Solutions, Mai- dictors of actuarial and technique survival. In addition to the 
vern, Pa., USA) using a standardized technique (75 kV, 4 mAs, diological parameters, other independent variables for m( 
180-cm film-focus distance; broad tube focus). The images were construction included age sex, body weight, mean of blood p 
assessed using a PACS (Magicview, Model VA22E, Siemens Med- sure, diabetes mellitus, Charlson's comorbidity score, serum 
ical Solutions) viewer (2K monitor). bumin, hemoglobin, total cholesterol, Kt/V, and residual G 
The method of VPW measurement has been described previ- Backward stepwise elimination was applied to remove the in 
ously [12]. Briefly, the right border of VPW was the point that nificant variables. 
superior vena cava crossed the right main bronchus. The left bor- Cox regression analysis was used to identify independent 
der was the point of subclavian artery exiting from aorta. The tors that affect hospitalization. Since these data were hi务 
VPW was defined as the horizontal distance measured between skewed, we determined the time to first hospitalization and c 
the two points. The distance of CTR was determined by the Dan- were expressed as hospkalization-free survival. The indepenc 
zer method [17]. The changes in VPW (AVPW) and CTR (ACTR) variables used for analysis were the same as those for surv 
in 12 months prior to enrollment were computed. All CXR were analysis described above, 
analyzed three times by two independent observers. The inter-
and intraobserver coefficients of variations were 2,9 and 6.1%, 
respectively. 
Results 
Dialysis Adequacy and Nutritional Assessment 
Nutritional status and dialysis adequacy were ^^^essed as de- ^ studied 212 PD patients. The baseline din: 
scribed in our previous studies 18-20]. Nutritional status was . . , . 」 . , , ， ” . , ， 内 
represented by normalized protein nitrogen appearance (NPNA)’ characteristics are listed in table 1. During the 12 mon 
fat-free edema-free body mass (FEBM), and serum albumin level, prior to enrollment, VPW of the patients rose from 53 
46 Kidney Blood Press Res 2009;32:45-50 Gao/Kwan/Chow/Chung/Leung/Li/Sz 
Table 1. Baseline clinical characteristics and biochemical profile 
of the patients — lertile i 
： ….-••.��—.. ： ••…Tertile II 
Characteristics f r . , 念 ; 、 ： V a l u e ^ ; „ � ---Tertile ill 
•j:严…‘'？ ^ . g “ 0.8- "P'-Vi, 
~ — _ 
Male:female 97:115 | ~ ^ 
Age, years 59.65 ±11.44 1 0.6-
Duration of dialysis, months 62.9 ± 38.0 2 ••… ^—— 
Body weight, kg 59.3±11.0 i \ _ …•.… 
Body height, m 1.59 ±0.08 ‘ i ’ • . 
Renal diagnosis, n (%) I … � - - “ , 
Glomerulonephritis 63 (28,6) , 飞 o：!- ’ • �-“,—• 
Diabetic nephropathy 54 (24.5) 
Polycystic kidney 7(3.2) J — n K test: p < 0 001 
Hypertensive nephrosclerosis 23(10.5) ^ I : I g 
Obstructive uropathy 15(6.8) Follow-up (months) 
Others/unknown 46 (20.9) 
Major comorbidity, n (%) 
Pi^betes 81 (38.2) , Kaplan-Meier estimates of hospitalization-free surviv 
”，mic heart disease 38 7.9 Patients were classified into tertiles of CTR. 
Cerebrovascular accident 27 (12./) 
Peripheral vascular disease 6 (2.8) 
Charlson's comorbidity score 5.16 ±2.13 
Hemoglobin, g/dl 8.81 ±1.75 . . , . , . 
Serum albumin, g/1 3 4 . 7 2 土 4 0 5 Relation With Clinical Characteristics 
Total Kt/V 1.88 ±0.38 We found that ACTR negatively correlated with 1 
Residual GFR, ml/mm/1.73 m^ 1.35 ± 1.76 moglobin (r = -0.204, p = 0.004), Kt/V (r = -0.249, p 
NPNA> g/kg/day 1.11 土 0.22 o.OOl), GFR (r = -0,198’ p = 0.005). However, ACTR ( 
FEBM, 55.30 ± 13.29 not correlate with age, duration of dialysis, or blood pr 
GFR = Glomerular filtration rate; NPNA = normalized protein sure. AVPW was higher in patients who required hyp 
nitrogen appearance; FEBM = fat-free edema-free body mass. tonic dialysate in the past year than those who did � 
(2.86 vs. 137, p = 0.026), but it did not correlate any ba 
line biochemical parameter. AVPW correlated with d 
stolic blood pressure (r = -0.185, p = 0.017) but not s 
tolic blood pressure (details not shown). 
Table 2. Cox proportional hazards model for the first hospital ad-
mission Relation with Hospitalization 
" T " ~ — During the 12-month follow-up, 141 (66.5%) patie 
Variable AHR 9 5 % C I > � ‘ pvalue admission to hospital and 78 patients (36,! 
ACTR, % 1.029 1.002-1.057 0.034 were admitted for CVD. At 12 months, hospitalizati 
Mean blood pressure, mm Hg 0.979 0.963-0.995 0.010 free survival was respectively 5L4, 37.5 and 17.9% 
Residual GFR, ml/min/1.73 m^ 0.753 0.641-0.883 <0.001 CTR tertiles I，II and III (log-rank test, p < 0.001) (fig 
— “ “ 7 By multivariate Cox regression analysis to control 
二HR = Adjusted hazard ratio; CI = confidence interval； confounders, ACTR (but not absolute CI 
S；： !：：^ cardi�thoradc raUo m 1 year; GFR = g W r - ^^^^ p r e s 匿 and residual GFR were indepenc 
！ — predictors of hospitalization-free survival (table 2), 
this model, a 1% increase in CTR confers 2.9% higher 
of hospitalization (95% confidence interval 0.2-5.7%, 
0.034). 
土 5.66 to 55.40 土 6.30 mm (paired Student's ttest, p < � . ， 
0.001); the mean AVPW over 12 months was 2.05 ± 4.79 Relation with Patient Survival 
mm. During these 12 months. CTR rose from 53.3 土 7.1 During the 12-month fol ow-up there were 23 de. 
to 56.0 土 7,80/) (p < 0.001); mean ACTR was 2.64 ± 1 patient had kidney transplants 3 changed to hem 
5 64% alysis, 2 moved to other units, and 2 terminated dial. 
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Fig. 2. Kaplan-Meier estimates of actuarial survival (a) and technique survival (b). Patients were classified L 
tertiles of CTR. 
The causes of death were CVD (7 cases), peritonitis (6 tion and loss of residual renal function may each contr 
cases), non-peritonitis infection (6 cases), others or urn- ute to malnutrition and hypoalbuminemia, which p< 
known (4 cases). Actuarial patient survival rate in 1 year sibly precipitates volume overload via a low plasma c 
was 87.7% and technique survival rate was 84.7%. The cotic pressure. In the present study, however, we did i 
actuarial survival was respectively 90.9, 89.9 and 81,8% observe any relation between CTR and serum albim 
for tertiles I, II and III (log-rank test, p = 0.247) (fig. 2a). level. 
Similarly, technique survival was respectively 89.4，87.0 Another finding was the relationship between AVF 
and 78.8% for tertiles I, II and III (log-rank test, p = 0.238) and hypertonic glucose solution. VPW changed to a la: 
(fig. 2b). Serum albumin and NPNA were the predictors er extent in patients with hypertonic dialysate than th( 
of actuarial survival; serum albumin was the predictor of without. It can be easily explained that hypertonic g 
technique survival (not shown in detail). CTR, ACTR, cose solution has a strong ability to remove much m( 
VPW, AVPW were not the predictors. fluid. It again proved that VPW was the indicator of v 
ume status: fluid accumulation leads to an increase 
VPW, resulting in a need for a more hypertonic cy( 
Discussion However, our study did not show any relationship 1 
tweeii AVPW and other variables. Since it is not alw； 
In our study, ACTR negatively correlated with hemo- easy to locate VPW on CXR, it is less likely that it is 1 
globin, Kt/V, and baseline residual GFR, but not with any reason for an undetectable relationship because our 
nutritional indices (serum albumin, NPNA, or FEBM). In tra- and interobservation variations were 6.13 and 2.9 
contrast, a previous study by Chen et al. [16] showed that respectively, which were all under 10%. Further stud] 
CTR is an indictor of nutritional status in hemodialysis still needed in this respect. 
patients. Our observation is in line with the conventional In the present study, during the 12 months of prosp 
wisdom that with a higher Kt/V or residual GFR, patients tive follow-up, ACTR was an independent predictor 
are less likely to have persistent fluid overload and there- hospitalization-free survival. It again supported the i 
fore CTR, which represents the body fluid status, would tion that ACTR reflects the change in intravascular \ 
tend to decrease [12,13]. On the other hand, body volume ume status, and it is generally accepted that fluid ov 
and nutritional status have been proposed to interplay load was one of the main contributors of CVD [5,6]. O 
with each other [22]. Notably, fluid overload could result er predictors of number of hospitalization-free survi 
in gastrointestinal edema, which may lead to anorexia in our study were in line with current literature. For 
and malnutrition [22,23]. In theory, systemic inflamma- tuarial and technique survival, CTR, ACTR, VF 
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AVPW were not the predictors, probably because of the more significance would be illustrated if patients were 
small sample size and limited statistical power of our unstable. Second, our study demonstrated that it may be 
study. necessary to monitor CTR and VPW frequently to mon-
Given the relatively young age and low comorbidity itor volume and nutrition status, but we are not sure about 
profile of our patient population, the number of subjects the interval between the two monitorings. Furthermore, 
who required hospitalization for CVD appeared quite although there are correlations with radiologic parame-
high. It is important, however, to note that we used a loose ters (CTR and VPW) and other clinical variables, the cor-
definition of hospitalization for CVD, and it is often dif- relations are often weak, indicating that the radiologic 
ficult to differentiate genuine heart failure from fluid parameters accounted for only a small percentage of vari-
overload secondary to problems of dialysis regimen or ation in the clinical variables. In other words, although 
dietary compliance. Since we performed CXR in all PD the correlation coefficients are statistically significant, 
patients in our center and recruited all available subjects, the clinical relevance remains arguable, 
the problem of selection bias seems unlikely. The crude In conclusion, the main finding in our study is that 
mortality of our present study was 10.8%, which was sim- ACTR negatively correlated with hemoglobin, Kt/V, and 
ilar to our previous studies [2’ 24]. It could be estimated GFR. Besides, ACTR is an independent predictor ofhos-
that a sample size of 4,640 would be needed to achieve pitalization-free survival. This simple radiological pa-
an 80% power and detect a 30% relative excess in mor- rameter may serve as an important parameter for the risk 
tality. stratification of PD patients. 
Some limitations need to be considered. First, our pa-
tients all had a stable status without clinical features of 
gross fluid overload because peritoneal ultrafiltrate re- Acknowledgements 
moves excessive fluid, which compensates for the loss of 刊 . ， � � . , , 
™ - a l function.Therefore VPW and CTR did 
not change too much during the study period, which may 
disguise some significant results. We speculate that much 
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